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Abstract
Multi-disciplinary areas of research like biomechanics or mechanobiology is providing
new insights, perspective and scientific frameworks to better understand complex bio-
physical processes. A particularly interesting bio-physical process is blood clotting. The
mechanical aspects of blood flow and its impact on blood cell responses are not well
understood, but can be studied from a robust perspective through the implementation of
different engineering tools including computational simulations, experiments, and mi-
crotechnologies
The aim of this thesis was to gain insight int the haemodynamics on experiments
recently performed in-vivo on mice and in-vitro using capillaries in blood flow. Using
this insight a micro-fluidic platform tailored to study the mechanical effects driving blood
platelet aggregation independent of biochemical triggers was developed. Detailed ac-
count of the haemodynamics of in-vivo and in-vitro experiments are presented as well
as the design, fabrication, characterisation of a microfluidic platform that utilizes micro-
contractions to test blood dynamics under different scenarios of dynamic strain-rates. The
microfludics platform was characterized using Computational Fluid Dynamics (CFD) and
micro-Particle Image Velocimetry. New proof-of-concept blood perfusion experiments
that illustrate the versatility of the device are also presented. The newly created platform
has been instrumental in elucidating a new mechanism of platelet aggregation that occurs
independent of the commonly accepted soluble agonist mediated pathways[1].
The main contribution of this work was building evidence through simulations and the
fabrication of a microfluidic platforms to support the claim that with the chemical mecha-
nisms of aggregation blocked, dynamic strain-rates produced by a micro-contraction, are
able to produce platelet aggregation and thrombus formation. The microfluidics platform
presented facilitates the detailed analysis of the effects of haemodynamics parameters on
the rate and extent of platelet aggregation and will be a useful tool to elucidate the haemo-
dynamics and platelet mechano-transduction mechanisms, underlying this mechanical-
dependent process.
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Chapter 1
Introduction
1.1 Motivation
The recent development of new multi-disciplinary areas of research like biomechanics or
mechanobiology, where physicist and engineers partner with biologist to explore differ-
ent biological phenomena where mechanics is involved, has provided new insights, per-
spective and scientific frameworks to better understand complex bio-physical processes
important for life sustainability. One of such processes is blood clotting which is a key
phenomena for the sustainability of normal blood flow in any human being, but under
abnormal conditions can produce diseases such as the acute coronary syndromes and is-
chemic stroke. The variables regulating thrombosis include hypercoagulability, endothe-
lial injury and blood flow parameters (haemodynamics). The former two variables have
been studied extensively and have a well defined role in arterial thrombosis. However,
the mechanism by which haemodynamics affects the thrombus formation process are not
well understood. With novel scientific frameworks, the role of haemodynamics on throm-
bus formation can be studied from a robust perspective through the implementation of
different engineering tools including computational simulations, experiments, and micro-
technologies. A better understanding of how blood clotting occurs will not only have
positive impact on basic science by increasing the knowledge on blood biology and its
dynamics but also in generating new devices to design better drugs and screen blood cell
functional defects.
1.2 Thesis Objective
This dissertation aims to gain deeper insight into the haemodynamics regulating throm-
bosis at micro-scale, by studying novel experiments recently performed on mice and cap-
illaries. Using this insight a micro-fluidics platform is presented to study the mechanical
1
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CHAPTER 1. 2
effects driving platelet aggregation independent of biochemical triggers (related to hy-
percoagulability and endothelial injury). This thesis presents a detailed account of the
design, numerical and experimental validation of a microfluidic platform that utilizes fo-
cally defined changes in strain-rate under non-recirculation conditions to probe platelet
dynamics in response to haemodynamics forces. The newly created platforms have been
instrumental in elucidating a new mechanism of platelet aggregation that occurs indepen-
dent of the commonly accepted soluble agonists mediated pathways[1]. Full details of the
design and validation of this platform technology as well as blood perfusion experiments
that demonstrates the basic haemodynamics parameters driving platelet aggregation are
also presented.
1.3 Contributions
The research presented in this work has resulted from a multidisciplinary work. There-
fore, my contributions need to be specified for the purposes of intellectual property
Chapter 2: I did not contribute at all to the experiments. This chapter is presented as a
background for the thesis. The experiments presented in this chapter were designed and
performed by researchers at the Australian Centre for Blood Diseases (ACBD).
Chapter 3: I proposed to study in detail the experiments done on mice described on
Chapter 2 by using numerical simulations. After several discussion with biologist from
ACBD during the timeframe of this research, I proposed to analyse the flow haemody-
namics using streamlines, which was an important step to facilitate the study of strain or
shear histories for a single platelet. I wrote the article for submission to the Journal of
Biomechanics[3].
Chapter 4: I performed the fluid dynamic simulations as a response to characterizse the
second set of experiments described in Chapter 2. The images from these analyses were
published in [1]. I proposed to analyse not only the strain-rate distribution at the surface
of the bead, but also the fluid streamlines. I compared these simulations with an analytical
solution.
Chapter 5: I designed several high resolution masks to perform a versatile micro-fabrication
process to test blood under several scenarios of micro-contractions. I fabricated the
moulds used for the polymer casting process of the device. I tested and implemented
ways to fabricate the reservoirs of the chip. I implemented a process to eliminate debris
from the fabrication process that could clog the micro-contraction. I designed and imple-
mented several debris traps. post-processing and analysis of µParticle Image Velocimetry
experiments. I performed the blood perfusion experiments and analysis of blood perfusion
experiments.
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CHAPTER 1. 3
1.4 Outcomes
During the timeframe of this PhD the following journal articles were produced:
W. S. Nesbitt, E. Westein, F. J. Tovar-Lopez, E. Tolouei, A. Mitchell, J. Fu, J. Carberry,
A. Fouras, and S. P. Jackson, “A shear gradient-dependent platelet aggregation mechanism
drives thrombus formation.,” Nat Med, vol. 15, pp. 665–673, Jun 2009. [1]
F. J. Tovar-Lopez, G. Rosengarten, E. Westein, K. Khoshmanesh, S. P. Jackson, A. Mitchell,
and W. S. Nesbitt. “A microfluidics device to monitor platelet aggregation dynamics in
response to strain rate micro-gradients in flowing blood., ”Lab Chip, vol. 10, pp. 291–
302, Feb 2010.[4]
F. J. Tovar-Lopez, G. Rosengarten, E. Westein, K. Khoshmanesh, S. P. Jackson, A. Mitchell,
and W. S. Nesbitt,“Structural and hydrodynamic simulation of an acute stenosis-dependent
thrombosis model in mice.,” J. Biomech, Accepted February 2011.[3]
Khoshmanesh K, Zhang C, Tovar-Lopez FJ, Nahavandi S, Baratchi S, Kalantar-zadeh
K, Mitchell A, “Dielectrophoretic manipulation and separation of microparticles using
curved microelectrodes,” Electrophoresis, 30(21):3707-3717, 2009.
Zhang C, Khoshmanesh K, Tovar-Lopez, F.J.,, Mitchell A, Kalantarzadeh K “Dielec-
trophoretic separation of carbon nanotubes and polystyrene microparticles,” Microfluid
Nanofluid, 7(5):633-645 2009.
Khoshmanesh K, Zhang C, Tovar-Lopez, F.J.,, S. Nahavandi, S. Baratchi, A. Mitchell,
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1.5 Overview of platelet aggregation
Blood is an essential but complex fluid that transport nutrients to vital organs and waste
products away from them. At the same time that regulates body pH and temperature.
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Blood acomplish its important functions by travelling around the body in blood vessels,
known as arteries and veins. Blood is composed of liquid (called blood plasma) and
various blood cells. Our organism has evolved in such a complex way that blood cells
contribute to the self repairing process of blood vessels when they are damaged, a process
known as blood clotting.
The key variables regulating thrombosis (the formation of a blood clot inside a blood
vessel) have been known for more than 150 years, and are known as Virchow’s triad.
These variables include changes in the vessel wall (endothelial injury), alterations in the
thrombogenic potential of blood (hypercoagulability) and changes in blood flow parame-
ters (haemodynamics)[5].
Blood clotting is a complex process that controls bleeding in case of an injury. How-
ever the same blood clots can, in response to some physiological conditions or disease
become life-threatening thrombi, which obstruct the natural blood flow to vital organs.
Blood clots can be either thrombocytes–rich clots (formed mainly from platelets), block-
ing the circulation to the myocardium and brain, leading to acute coronary syndromes and
stroke or erythrocyte–rich clots (formed mainly from red cells) which can embolize from
the deep veins and threaten the lungs with pulmonary emboli.
This investigation will be focused on the thrombocytes–rich clots formed by platelets.
Platelets are highly specialized blood cells that have evolved to develop the complex func-
tion of repairing the blood vessel w ll (endothelium) when damage occurs. Platelets repair
the blood vessel wall by accumulating together driven by biochemical and haemodynam-
ics processes. The methods by which proteins from the injured vessel wall and blood
borne chemical factors interact with platelets have been investigated extensively[6, 7, 8,
9, 10] however the critical haemodynamics parameters and their effects on platelet func-
tion and aggregation have been less well defined.
1.5.1 Chemical factors on platelet aggregation
From the perspective of biochemical factors affecting platelet aggregation, it is understood
that platelets are able to clump together under the influence of flow using two proteins
present in blood plasma as a connecting agent. These proteins are fibrinogen (only present
in the fluid blood) and von Willebrand factor (vWF, present both in the blood and also in
the vessel wall), which becomes exposed when there is an endothelial injury . The process
of platelet adhesion to the vessel wall and to each other is performed by the cooperative
function of two important platelet adhesion receptors, glycoprotein Ib (GPIb) and integrin
αIIbβ3, with the relative contribution of each receptor dependent on local haemodynamics
conditions [9]. These platelet receptors play important roles in cell signaling, as they
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transduce information from the vessel wall to the cell as well as reveal the status of the
cell to the outside, allowing rapid and flexible responses to changes in the environment.
On the other hand, along with this internal cell signalling, blood borne chemicals
(adenosine diphosphate -ADP-, thromboxane A2 TXA2 and thrombin) are able to trigger
a series of biochemical and functional platelet responses that coincide with the devel-
opment of platelet aggregates[11, 9, 10, 12]. Some of these platelet responses include
intracelullar calcium flux, platelet shape change and granule release. However recent
observations demonstrate that platelets can form aggregates in-vivo without a detectable
increase in intra-cellular calcium[13, 14], without undergoing shape change[14, 15], and
without a substantial granule secretion[16].
1.5.2 Mechanical factors on platelet aggregation (Haemodynamics)
From a fluid mechanics perspective, observations have indicated that platelets in flowing
blood tend to aggregate at certain sites in the arterial system such as downstream from bi-
furcations, sharp bends, constrictions, implanted rings in the vena cava and aneurysm[17,
18, 19]. From fluid mechanical considerations it can be shown that bifurcations, T-joints,
sharp bends and constrictions are places where flow is disturbed and where the formation
of vortices (eddies) can occur[20].
How fluid stress from haemodynamics can produce damage in the blood vessel wall
(endothelium) has been a matter of several studies (see review of Berguer[21]). However
this investigation will be focused on how haemodynamics affects blood cells, specifically
to platelets.
Because platelet aggregates form at sites where flow is disturbed, fluid mechanical
factors have been cited as a cause of thrombus formation[22]. A number of computa-
tional and experimental models of platelet flow through vascular stenoses, consisting of
geometries with scales in the order of millimeters and blood flow with Reynolds numbers
≥ 100, have been carried out[23, 24, 25, 26, 27, 28]. Under these Reynolds numbers,
flow may not be laminar and platelets may experience both regions of high shear-rate and,
more significantly, zones of recirculating flow, downstream of stenoses. A long standing
assumption has been that platelet activation and aggregation within regions of blood flow
recirculation is promoted via diffusion and advective transport of blood-borne aggrega-
tion agonists [17, 29, 30], leading to platelet activation and shape change. In some other
studies platelet aggregation on stenosis geometries has been reported to be found on the
apex of the stenoses, where the highest stress is present [31].
The other mechanical factor involved is related to the viscous stress and forces related
to this stress. According to the Newton’s law of viscosity, any fluid moving into a vessel
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experiences a viscous stress that is proportional to the flow velocity. Normal variations
of viscous stress regulate changes in vascular diameter and when sustained induce slow,
adaptive, structural-wall remodeling[32]. Both processes are endothelium-dependent and
are compromised by hypertension, diabetes and inflammatory disorders. This viscous
stress produced by the blood flow is in turn experienced by the cells transported and by
the endothelium as viscous forces. These forces can enhance the interaction of cells and
proteins, stretch cells and proteins, serve as a triggering factor for some mechanotrasduc-
tion processes, can be involved on mass transport phenomena as advection mechanisms,
or deform the cell membrane.
Blood cells and plasma proteins, experience a range of mechanical forces that can
have a significant effect on cellular function and signaling. Regions of flow disturbances
including arterial branches, bifurcations, curvatures and narrowing (stenosis) result in
complex fluid forces and their characteristics can predict atherosclerosis susceptibility
[32]. More importantly, in zones of flow disturbance, these forces may not be constant
but dynamic. Experimental models comparing the effect of constant versus time vary-
ing or pulsatile shear forces on platelet aggregation dynamics have demonstrated that
platelets are highly attuned to both temporal and spatial variations in shear forces in con-
trast to steady state conditions[33, 34, 35, 36]. A distinctive feature of the majority of
previous investigations listed is that either they have been conducted primarily on large
blood vessels (500µm-2mm), producing large Reynolds numbers or on Couette cells. A
long standing but poorly supported assumption in these bio-physical studies has been that
platelet activation and aggregation within regions of blood flow recirculation is promoted
via diffusion and advective transport of soluble platelet agonists, leading to platelet shape
change and activation.
1.5.3 Micro-technology brings new discoveries on platelet aggrega-
tion
With the recent development of better imaging systems that allow observation of blood
flow through small arteries, a deeper insight into the platelet response under dynamic flow
conditions has been possible. Furthermore advances in drug development on platelet bi-
ology have enabled experimental designs where platelet chemical receptors are blocked.
Recent studies using high quality imaging on mice, demonstrate that even with the chem-
ical mechanisms of aggregation blocked, platelet can aggregate in an inactive state un-
der conditions of perturbed blood flow[1], suggesting that fluid forces can directly drive
platelet aggregation independent of biochemical triggers. The former experimental ob-
servations served as motivation to investigate the flow conditions of the biological experi-
ments by trying to emulate the phenomena on a synthetic device, using micro-technology.
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By investigating the conditions found in the micro-vasculature, this thesis aims to develop
a laminar flow system that emulates such conditions and provides localised disturbances
that are of similar size to the platelets themselves. Using this new platform it is hoped
that platelet responses can be investigated with unprecedent clarity.
1.6 Thesis Outline
Chapter 2 sets the scene for the present thesis by reviewing two different model ex-
periments where platelet aggregation was observed under the chemical receptors of the
platelets blocked. The experiments were done by personnel of the Australian Centre for
Blood Diseases. Chapter 3 presents the mechanical modelling of the first experiment
presented in Chapter 2, (an artificial stenosis or contraction) by using finite element anal-
ysis and computational fluid dynamics to emulate the experiment and gain insight into
the haemodynamics governing the conditions of an artificial stenosis in mice. Chapter 4
presents the study of the second experiment presented in Chapter 2, (spherical micro-
protusion) by using both, an analytical and a numerical simulation of the flow around a
spherical protusion. Chapter 5 presents a pro f-of concept microfluidic platform that uses
micro-contractions to emulate an artificial stenosis on a synthetic device. This synthetic
platform allows independent variation of a number of fluidics characteristics and this
finally provides the required experimental evidence to conclude that mechanical forces
alone may initiate platelet aggregation. The conclusions and future work are summarized
in Chapter 6.
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Chapter 2
Review of biological experiments at
Australian Centre for Blood Diseases -
Monash University
2.1 Contributions
I did not contribute at any part of the experimental work described on this chapter. This
chapter is presented as background for the rest of the thesis. The experiments described
in this Chapter were designed and performed by researches at the Australian Centre for
Blood Diseases (ACBD) and have been published in:
W. S. Nesbitt, E. Westein, F. J. Tovar-Lopez, E. Tolouei, A. Mitchell, J. Fu, J. Carberry,
A. Fouras, and S. P. Jackson, “A shear gradient-dependent platelet aggregation mechanism
drives thrombus formation.,” Nat Med, vol. 15, pp. 665–673, Jun 2009. [1]
2.2 Introduction
Platelet activation and associated aggregation is a complex process that occur through the
synergistic signaling effects of exposed sub-endothelial matrix proteins (vascular factors),
blood borne biochemical activators (thrombin, ADP and TXA2) and blood flow depen-
dent mechanical factors (haemodynamics). Therefore, it is a process hard to study under
controlled conditions. This Chapter presents two different model experiments developed
at the Australian Centre for Blood Diseases which settled the basis for proposing a new
mechanism of platelet aggregation. The experiments are presented here to set the scene
for the rest of the thesis.
9
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Historically in-vitro experimental approaches examining blood flow have been con-
ducted using parallel flow chambers, Couette cells [37, 38, 39] or rectangular capillar-
ies [40, 41, 11, 6, 7], in an attempt to reproduce platelet aggregation phenomena at the
laboratory. With these studies, it has been long recognized that platelet aggregation prefer-
entially occurs at regions of flow disturbance after vascular injury where chemical factors
play a primary role. These flow disturbances can be understood as stenoses (regions where
the blood vessel suddenly contracts and expands), blood vessel bifurcations, protrusions
or bumps formed by the accumulation of cells or fatty materials.
As it was presented in Section 1.5.1 some of the platelet chemical responses include
intracelullar calcium flux, platelet shape change and granule release. However recent
observations demonstrate that platelets can form aggregates in-vivo without a detectable
increase in intra-cellular calcium[13, 14], without undergoing shape change[14, 15], and
without a substantial granule secretion[16]. These observations suggested that additional
mechanisms may be involved in the process of platelet adhesion and aggregation. These
observations served as a motivation to investigate platelet aggregation using different ap-
proaches by implementing new experimental techniques. Specifically the experiments
described in this Chapter include the implementation of advanced imaging techniques to
study platelets from a closer and clearer approach.
The first experiment refers to the development of an acute arteriolar stenosis model
adapted from the murine mesenteric model of acute thrombosis. This method involves
the generation of a stenosis of mesenteric vessels via the progressive compression of the
vessel side wall using a blunted micro-injection needle at a site of vessel wall injury ( [1]),
and its observation using intra-vital imaging techniques. Platelet aggregation was found
despite chemical factors being blocked, in the downstream face of the stenosis, rather than
in the maximum contraction where the highest shear is expected [31].
On the other hand, the second experiment refers to a modification of a commonly used
device in blood research: the rectangular capillary. Rectangular capillaries in particular
have become popular in recent years due to their relative ease of use and easy application
to transmitted light micro-imaging techniques. A method was developed to locally modify
the capillaries to initiate single platelet adhesion at a pre-defined location, modifying the
surface of the capillary to create a flow disturbance, similar to Chapter 3, but using a
canonical disturbance (sphere of controlled size).
This Chapter presents these two different novel experiments in blood research which
set the scene for the coming chapters. Section 2.3 reviews the in-vivo experiments done
on mice where an artificial stenosis is produced with a micro-needle on an arteriole. Sec-
tion 2.4 presents a review of a number of in-vitro experiments where blood is flowed
through rectangular channels with micro-beads immobilized on the wall.
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The experiments were done by researches at the Australian Centre for Blood Diseases.
Because of their importance and intrinsic relationship to the development of this PhD, they
are presented in this document as introduction.
2.3 Review of in vivo disturbance with an artificial steno-
sis on mice and blocked chemical receptors
Experiments with artificially induced stenoses provide the most realistic model to study
the effects of rheological disturbance on platelet aggregation dynamics. This Section
presents a review of experiments done on mice where an artificial stenosis is produced
with a micro-needle on an arteriole and platelet aggregation was observed. The experi-
ments were designed and performed at the Australian Centre for Blood Diseases (ACBD).
2.3.1 Description of the experiment done by the ACBD
An experiment was conceived at the ACBD using a blunted needle to compress a capillary
vessel in a live mouse to promote a local change in blood flow velocity. The mouse used
was from a strain genetically modified and treated with drugs which blocked many of the
biochemical and functional platelet responses, effectively turning off the mechanisms for
chemical initiation of platelet aggregation and thrombus formation. The aim of this ex-
periment was to discover whether it was possible to still form a thrombus through simple
mechanical stresses.
The experiments were performed using intra-vital imaging to visualize the platelet
aggregation process in mesenteric arterioles of mice. The mice used was from a genet-
ically modified strain, P2Y 1−/−, which lack the platelet receptor P2Y 1 an adenosine
di-phosphate (ADP) receptor. Furthermore clopidogrel was administrated causing com-
plete inhibition of ADP-induced platelet aggregation, whilst aspirin and hirudin were also
introduced to block thromboxane and thrombin generation respectively. The mouse was
anesthetized and an injury was performed in their mesenteric arterioles (40–160 µm). The
degree of stenosis was controllably manipulated using a blunted micro-needle positioned
at a site of vascular injury. Platelet interactions was visualized by DIC microscopy using a
Leica DMIRB inverted microscope (objectives: 100X PL APO, numerical aperture 1.40–
0.7 and 63X HCX PL APO, numerical aperture 1.2) and a DAGE MTI charge–coupled
device camera.
Figure 2.1 presents a micro-graph of the experiment with images captured over a
20 second period with the needle being inserted and removed. An aggregate is clearly
observed when the needle is inserted and this dissipates when the needle is removed.
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It is observed that initial platelet recruitment occurred specifically at the stenosis apex
(Fig. 2.1), with the subsequent formation of platelet aggregates occurring in the down-
stream expansion zone. Localized stenosis markedly accelerated the rate and extent of
platelet aggregation (Fig. 2.1, 16.39 s). Platelet aggregation was observed throughout the
expansion zone, but aggregation rapidly ceased at the downstream margin of this zone,
suggesting that the stenosis had a spatially restricted effect on thrombus growth.
Figure 2.1: Review of mice experiment at ABCD. Micro-graph of the experiment. After stenosis
(11.87 s), a marked increase in platelet aggregation was observed (blue arrow), which specifically
developed downstream from the site of vascular injury (red arrow). Aggregate growth ceased at
the downstream stenosis margin (yellow arrow; 16.39 s) where the vessel returned to its native
geometry. Subsequent removal of the micro-needle led to the rapid embolization of the platelet
aggregate (24.13 s). Scale bars, 10 µm.
Figure 2.2 presents an analysis of the thrombus size (% of the maximum size) as a
function of compressing the vessel over time at different times, showing that the aggre-
gation is repeatable and th re is a distinct threshold for aggregate formation. Thrombus
formation was dynamic with cycles of aggregation and disaggregation corresponding to
serial increases and decreases in stenosis, with removal of the micro-needle leading to
disaggregation of the platelet mass (Fig. 2.1, 24.13 s and Fig. 2.2)
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Figure 2.2: Review of mice experiment at ABCD. Aggregation as a function of time. Relative
thrombus size a function of inducing the stenosis several times. Gray areas show application of
the needle.
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From these experiments it can be concluded that a micro scale stenosis can induce the
formation of aggregates. Since the strain of the mouse used lacked the ADP receptor and
the experiment was conducted under the action of specific drugs to block the aggregation
due to thromboxane and thrombin, it is suggested that the aggregation is likely driven by
non-chemical factors. One possible mechanism may be relying on the haemodynamics.
Since the geometry of the vessel is the most remarkable variable, it is possible that the
contribution of haemodynamics is the underlying mechanism of aggregation
2.4 Review of in vitro disturbance using a spherical pro-
trusion with blocked chemical receptors
Section 2.3 presented an in-vivo experiment where a micro-needle was used to create
an artificial stenosis which could initiate platelet aggregation under conditions where the
common chemical activating mechanism of platelet aggregation were blocked. Signifi-
cantly, platelet aggregation was found to occur in the deceleration zone of the stenosis
rather than in the high shear zone as has been reported in earlier studies [31, 42, 43].
Using the experimental in-vivo approach described in Section 2.3 it was found that
although the peak strain-rate could be accurately controlled using the degree of steno-
sis, the total strain-rate history including acceleration and deceleration components was
highly variable and dependent on parameters such artery wall elasticity which is difficult
to control in a systematic manner. Given that platelet aggregation was found exclusively
in the deceleration zone of the in-vivo stenosis, it was hypothesised that not just high
strain-rates but the total strain-rate history is a significant factor in determining platelet
aggregation which may explain why aggregation is only observed under certain specific
in-vivo experimental conditions.
Due to the fact that in-vivo parameters are highly complex and difficult to control, with
variations existing in geometry, elasticity, platelet function and chemical environment, it
was very difficult to conceive of an in-vivo experiment that could prove the importance
of total strain-rate history in the initiation of aggregation. It was thus decided to pursue
a simplified in-vitro model that could isolate the parameters of interest while eliminating
many of the variables encountered in the in-vivo experiment.
Historically in-vitro experimental approaches examining blood flow have been con-
ducted using parallel flow chambers, Couette cells [37, 38, 39] or rectangular capillar-
ies [40, 41, 11, 6, 7]. Rectangular capillaries in particular have become popular in recent
years due to their relative ease of use and easy application to transmitted light micro-
imaging techniques.
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Since the cross sectional area of a rectangular capillary is constant along the direction
of flow, the fluid at any point in the cross-section experiences a constant velocity and
constant shear-rate as during steady. The rectangular capillary is thus an excellent tool for
studying the role of haemodynamics at a constant shear-rate on blood cells. Capillaries
can also be easily coated with specific proteins to study the function and interaction of
platelets under a wide range of constant shear-rate.
A number of experiments were conducted to study platelet-protein matrix interactions
under flow at the Australian Centre for Blood Diseases [33, 44]. During some of these ex-
periments, it was observed that occasionally single platelets adhered to the surface of the
capillary and this by itself was apparently sufficient factor to trigger platelet adhesion and
subsequent accrual of new platelets from the flow (unpublished observations). However
due to the stochastic nature of platelet-surface interactions under flow it was difficult to
predict where an platelet aggregation would occur. Based on these limitations a method
was developed to locally modify the capillaries to initiate single platelet adhesion at a
pre-defined location, modifying the surface of the capillary to create a flow disturbance,
a concept similar to Section 2.3, but using a canonical disturbance that could be easily
controlled and analysed.
This Section presents a review of a series of experiments of micro-bead collision as-
says designed and performed at the Australian Centre for Blood Diseases which resulted
in the observation of controlled platelet aggregation.
2.4.1 Description of the experiment done by the ACBD
An experiment using a micro-spherical protrusion was conceived at the Australian Centre
for Blood Diseases by making a modification to a commercially available micro-capillary
platform with the aim of observing in real time the blood cells behavior under a localised
and size-controlled flow disturbance. The micro-sphere experiments were performed ac-
cording to a modification of a published method [45]. Since platelets are blood cells of
discoid shape (2µm × 0.3µm), fixed polystyrene micro-spheres with similar size diame-
ters 2, 5, 9 and 15µm were used. The micro-spheres were precoated with purified human
von Willebrand factor (vWF) and immobilized at the surface of glass micro-capillaries.
Sphere concentration near the inlet or outlet of the capillary due to sedimentation ef-
fects was neglected since the experiment was performed on beads adhered at the middle
of the longitudinal section of the capillary. Blood was treated to inhibit the chemical
mechanisms of platelet aggregation (soluble agonists) for 10 minutes with the platelet
inhibitors; MRS2179 (100µM ) and 2-MeSAMP (10µM ) — to block ADP platelet aggre-
gation; Indomethacin (10µM ) — to block thromboxane (TXA2) generation; and hirudin
(800U/ml) — to block thrombin generation. Blood flow was infused under positive
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pressure using a syringe pump. The flow rate was adjusted to produce a shear-rate of
γ˙ = 10, 000s−1 at the bottom and top wall of the micro-capillary. A separate capillary
was used for each bead size. The calculated Reynolds number was 0.01 and 0.64, depend-
ing on the bead size. Figure 2.3 presents a diagram of the experiment.
200µm    2
0
0
0
 µ
m
8 cm
micro-beads
blood flow
glass capillary rectangular device
Figure 2.3: Diagram of the spherical micro-protrusion experiment in capillary channels.
Figure 2.4 presents optical Differential Interference Contrast microscope (DIC) im-
ages of discoid platelet aggregates, at the downstream face of the sphere. Figure 2.4a),
shows that the size of the aggregate becomes larger as function of the bead size for the
same flow parameters and channel cross-section. A stable thrombus formation is evident
for the 15µm bead (Re 0.64) and some unstable single platelets are observed at the back of
the 2µm bead (Re 0.01). From a biological perspective it is of interest to note that the sin-
gle platelets retain a discoid morphology, suggesting that the platelets have not undergone
overall shape-change indicative of chemically induced platelet activation [46, 47, 48, 49]).
The discoid shape of the platelets can be observed in the Figure 2.4a) and more specif-
ically in the 2µm bead. Figure 2.4b) presents the aggregate size as a function of bead
diameter. This measurement is made as a two dimensional cross-section, since three di-
mensional aggregate information could not be derived from the DIC imaging approach
used. It is interesting to note that if the thrombus area simply scaled in proportion to the
bead diameter, then the thrombus area should scale with the square of the bead diame-
ter. It is evident that in fact the thrombus area scales only linearly with bead diameter
indicating that the thrombus shape changes significantly as the bead diameter reduces.
This type of experiment is novel [1] and hence there was no previous information
on what may have triggered the platelet accumulation at the back face of the sphere. It is
evident that the micro-sphere constitutes a very localised fabricated defect where platelets
aggregate. The micro-sphere is able to locally change the haemodynamics, therefore it is
hypothesised that some factor from the haemodynamics is governing the aggregation.
2.5 Conclusion
From these experiments it can be concluded that a micro-scale flow disturbance steno-
sis can induce the formation of platelets aggregates. Since the strain of the mouse used
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Figure 2.4: Review of bead collision assay from [1]. a) DIC image frames showing the nature and
extent of discoid platelet aggregation at the downstream face of vWF-coated micro-beads after
whole-blood (pretreated with 100µM MRS2179, 10µM 2-MeSAMP, 10µM Indomethacin and
800U/ml hirudin) perfusion at an applied γ˙ = 10, 000s−1 (n = 5). Re 0.01-0.64. Aggregation
occurs exclusively at the downstream (zone 3) face of the beads, and aggregates can extend up to
seven bead diameters (zone 3) downst eam of initial platelet-bead adhesion, with overall aggregate
width correlating with bead diameter. Top view is shown for all beads. (b) Mean discoid platelet
aggregate size (surface area in µm2 +/- s.e.m.) as a function of micro-bead diameter (n = 3).
lacked the ADP receptor and the experiment was conducted under the action of specific
drugs to block the aggregation due to thromboxane and thrombin, it is suggested that the
aggregation is likely driven by non-chemical factors. Since the geometry of the vessel is
the most remarkable variable, it is possible that the contribution of hemodynamics is the
underlying mechanism of aggregation. The same can be said for the spherical protrusion
assay, which was conducted using blood under the action of chemicals to block platelet
aggregation and the flow disturbance generated by the sphere produce platelet accumula-
tion at the back face of the sphere. Therefore since the micro-sphere is a very localised
fabricated defect where platelets aggregate, which change locally the haemodynamics, it
is hypothesised that some factor from the haemodynamics is governing the aggregation.
Thus in both cases it would be of benefit to know precisely the haemodynamics con-
ditions at the micro-scale, particular what flow disturbance they produce, and what strain-
rate distribution may be found at the location of the aggregates. Chapter 3 presents the
mechanical modelling of the first experiment (an artificial stenosis or contraction) by us-
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ing finite element analysis and computational fluid dynamics to emulate the experiment
and gain insight into the haemodynamics governing the conditions of an artificial stenosis
in mice. Chapter 4 presents the study of the second experiment presented in Chapter 2,
(spherical micro-protrusion) by using both, an analytical and a numerical simulation of
the flow around a spherical protrusion.
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Chapter 3
In-vivo disturbance: induced stenosis
on mice arterioles
3.1 Contributions
I proposed to study in detail the experiments done on mice described on Chapter 2 by us-
ing numerical simulations. After several discussion with biologist from ACBD during the
timeframe of this research, I proposed t analyse the flow haemodynamics using stream-
lines, which was an important step to facilitate the study of strain or shear histories for a
single platelet. I wrote the article for submission to the Journal of Biomechanics[3].
The content of this chapter has been published with small modifications in:
F. J. Tovar-Lopez, G. Rosengarten, E. Westein, K. Khoshmanesh, S. P. Jackson, A. Mitchell,
and W. S. Nesbitt,“Structural and hydrodynamic simulation of an acute stenosis-dependent
thrombosis model in mice.,” J. Biomech, Accepted February 2011.[3]
3.2 Introduction
Flow disturbance is a principal driver of platelet aggregation and may result from vessel
narrowing (stenosis) due to crush injury, vessel wall thickening, stent placement, neointi-
mal thickening and reduction of vessel lumen diameter following angioplasty ([17, 18,
19]). The effects of stenosis on haemodynamics have been studied using both com-
putational and in-vitro modelling approaches on large arteries (Reynolds ≥ 100, see
[23, 20, 28, 50, 51, 52, 53, 27, 26, 54, 55, 31, 24, 25]).
18
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Under these conditions, blood cells may experience both regions of high shear-rate
and, more significantly, zones of recirculating flow, downstream of stenoses. A long
standing assumption has been that platelet activation and aggregation within regions of
blood flow recirculation is promoted via diffusion and advective transport of blood-borne
aggregation agonists, leading to platelet activation ([17, 29, 30]). A distinctive feature of
the majority of previous investigations listed is that they have been conducted primarily
on large blood vessels (500µm-2mm).
Advances in intra-vital imaging techniques and the widespread and increasing use of
thrombosis models involving rodents have facilitated the study of platelet responses under
dynamic and laminar conditions (Reynolds ≤ 1). As it was shown in Chapter 2, recent
biological experiments developed by the Australian Centre for Blood Diseases, Monash
University [1] have established that rapid changes in shear-rate in micro-flows can trigger
platelet thrombus formation in the absence of the commonly accepted chemical activa-
tors (ADP and thromboxane) of platelet activation and aggregation ([1]). A significant
outcome of these studies is the recognition that shear gradients at the micro-scale may
underlie the lack of efficacy of common anti-platelet drugs such as aspirin ([56]) and
clopidogrel ([57]). A key experimental advance underlying this discovery was the devel-
opment of an acute arteriolar stenosis model adapted from the murine mesenteric model of
acute thrombosis. This method involves the generation of a stenosis of mesenteric vessels
via the progressive compression of the vessel side wall using a blunted micro-injection
needle at a site of vessel wall injury ( [1]).
These experiments with artificially induced stenoses have provided the most realistic
model reported to date but only allows limited control over the geometric variables, since
only the needle width and displacement can be controlled with any precision thus it is
hard to know precisely the parameters of the stenoses geometry that has been induced
and thus it can be difficult to analyse the fluid dynamics of blood flowing through such a
stenosis. Figure 3.1 illustrates possible variables that may be of significance in an in-vivo
experiment.
In these experiments, platelet aggregation occurred at the downstream face of the ap-
plied stenosis (flow deceleration), rather than within the stenosis throat where shear rates
are at their highest. The findings of these experiments arguably suggested that mechani-
cal or haemodynamics variables may play an important role in platelet aggregation when
blood is flowing in micron scale capillaries with low Reynolds number.
One important discovery from the biological perspective was the observation that dis-
coid platelet aggregates can form through the development of membrane tethers, indepen-
dent of integrin and platelet activation. This observation is in contrast to the historically
accepted theory that chemical activation is crucial in the initiation and formation of aggre-
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Lc
Ao
Ar
 % Stenosis_Area=
Ao-Ar
Ao
X 100
θc θe
lo: Initial diameter
lr:  closest distance
Ao: Initial area
Ar:  Reduced area
Lc:  Length of contraction
θc:  Angle of contraction
θe:  Angle of expansion
 % Stenosis_linear=
  lo-lr
lo
X 100
lo
lr
Figure 3.1: Variables defining a stenosis.
gates. One of the frequent observations in the experiments was that platelet aggregation
usually tended to occur in regions of rapid changes in blood flow parameters, in particular
where significant changes in fluid shear-rates were observed over micron scale distances
- so called shear micro-gradients.
To better understand the biology of platelet aggregation and its relationship to the fluid
mechanic environment, it is necessary to know precisely the velocity of the fluid at the re-
gion of the stenosis. Knowing the fluid velocity subsequent calculations can be performed
like the fluid deformation rates (called strain-rates) and the fluid stresses. Thus, there is
a persistent challenge to identify the best engineering approach to accurately model the
physical form of a stenosis and quantify the haemodynamics of blood flow within this
form.
As presented in the Chapter 1, a major goal of this thesis is to investigate the effects of
the mechanical and geometrical parameters on fluid flow of stenosed micro-vessel and its
effect in the initiation and promotion of platelet aggregation. It is the goal of this chapter
to identify the main parameters in the specific in-vivo experiment where a micro-needle is
used to create an artificial stenosis in micro-capillaries of mice. Section 3.3 presents a lit-
erature review on fluid simulation of stenosis. Section 3.4 presents a qualitative model of
the stenosed micro-capillary generated by choosing a specific stenosis geometry and sim-
ply subjectively drawing that geometry in three dimensions. Computational fluid dynam-
ics were used to model the stresses that could be experienced by blood flowing through
this geometry. A Newtonian and two Non-Newtonian models are implemented for com-
parison purposes. From this investigation an appreciation for the approximate order of
magnitude of the variables in play was obtained. In particular it was possible to deter-
mine that blood flow was experiencing a sudden change of strain-rates in a short distance.
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A second approach is described in Section 3.5. This second approach aimed to provide
a more accurate model of the stenosis geometry by mechanically modelling the capillary
as an elastic tube encased in soft tissue which is deformed of stenosis corresponding to
different displacements of the needle. In particular it was possible to produce geometric
models of extreme stenoses where the cross-sectional area was reduced by up to 90%.
Computational Fluid Dynamics was again used to model the strain-rates that would be
experienced by blood flow flowing through these geometries and these strain-rates were
compared to canonical models reported in the literature. A number of key geometric fea-
tures were identified and it was found that the elastic properties assumed for the capillary
walls are critical in determining the form of the stenosis. Section 3.8 summarizes the
findings of this Chapter, and describes how the insight gained can be used to construe
new experiments utilizing micro-beads and microfluidic channels that will be discussed
in Chapter 5.
3.3 Literature Review on numerical models of stenosis
This section presents a brief review of different works on modelling stenosis. Because of
observations that atherosclerotic lesions preferentially occurred in blood vessels in regions
of flow disturbance, and flow disturbance has been associated with turbulence, stenosis
has been a subject of study for several disciplines[21]. Just the combination of words
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Figure 3.2: Scientific articles published with the terms stenosis, stenoses or stenotic, extracted
from the database Web of Science, from 1992 to February 2011, including all areas of research.
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"stenosis", "stenoses", "stenotic", at the scientific database Web of Science produce more
than 85,000 articles, from all areas of knowledge, including medicine, biology, mathe-
matics, engineering, mechanics, and computer science. Figure 3.2 shows the amount of
articles published per year containing this combination of words. From this number of
articles, around 20% are related with cardiovascular and cardiology studies, that involve
mathematics, engineering, computer sciences, mechanics or biophysical Sciences.
From this high number of publications it was of interest to analyse which of them
could help to get insight in the experiments done on mice described in Section2.3. Be-
cause the experiments were done on arterioles from a live mice, and low Reynolds number
(< 1), the presented review was focused to analyse the type of geometry and the Reynolds
number used in the investigations. A secondary analysis was focused on the type of fluid
they model (Newtonian or Non-Newtonian, Homogeneous or Non-Homogeneous). Ta-
ble 3.1 presents a summary of this review including the most representative articles with
a distinctive feature judged by this candidate.
The first column of Table 3.1 refers to the geometry used for the investigations,
grouped as idealized in 2D, 3D, and realistic in 2D and 3D. The second column refers
to the type of viscosity used, whether is Newtonian or No-Newtonian. The third column
includes the author of the investigations. The fourth column on Table 3.1 presents the
Reynolds number range of the investigations selected for this review. In this respect it is
worth to note that it has been widely accepted that blood flow recirculation is a key factor
in thrombus formation, therefore it is common to find that the models described on math-
ematics, engineering, computer sciences, mechanics or biophysical sciences, are focused
on turbulence or higher Reynolds number than the one used for the present investigation.
The fifth column refers to the type of geometry used. In this respect, the fact that the
experiments were done on live mice, makes an important difference with most investi-
gations from Mathematics, Engineering, Computer Sciences, Mechanics or Biophysical
Sciences, where usually the geometries are idealized or modelled using cosine functions.
On the other hand, in medical or cardiology areas, where real vessels are studied, the
investigations are either focused to clinical research and no present studies on haemody-
namics, or using much larger arteries. Therefore it was of interest to find articles using
real vessel geometries to include any three dimensional effects and low Reynolds number.
It has been widely accepted for non-medical sciences, to model the stenosis using
cosine functions. This allows researches to formulate questions related to haemody-
namics, turbulence or new algorithms to solve the fluid motion equations. There are a
high number of works using cosine functions, and two dimensional geometries, some of
them include [42, 58, 59, 60, 61]. Investigations including Non-Newtonian viscosity or
Non-Homogeneous fluids include [62, 63, 64, 58, 65]. The work of Fogelson[63, 64] is
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particularly interesting since his research deals with modelling the process of platelet ag-
gregation considering advective transport of chemical agonists, in his research they used
two dimensional geometries of idealized rectangular shaped stenosis.
Table 3.1: Review on numerical models of stenosis.
Stenosis Models
Geometry Viscosity Author Re Comments
Idealized 2d
Newtonian Wootton[42] 160 cosine
Varghese[58] 600 cosine
Griffith[59, 60] 50-2500 circular
Banerjee[61] 50-400 cosine, trapezoidal
Non-Newtonian Tu[62] 67-130 cosine, Herschel
Fogelson[63, 64] model of p.a.
Sorensen[58] 600 model of p.a.
Sankar[65] – cosine, Casson
Idealized 3d
Newtonian Bark[66] 230 cosine
Blackburn[67] 400 cosine, pulsatile
Bluestein[26] 300 to 3,600 cosine
Sherwin[68] 400-800 cosine axisym.
Schoephoerster[52] 300-3600 cosine, axisym, exper.
Vetel[69] 100-1100 cosine,PIV, turbulence
Anderson[70] 500-2000 cosine, irregularities
Non-Newtonian Raz[25] 200 cosine, eccentric
Jung[71] 575-900 cosine, Casson
Strony[51] 340-472 square, rect, Carreau
Realistic 2d
Newtonian Kock[72] Magnetic resonance,
Marshall[73] Magnetic resonance,
Non-Newtonian
Realistic 3d
Newtonian Tovar[3] 0.45 Elastic model of mice
(model presented
in this chapter)
Non-Newtonian —– ———-
The second row of Table 3.1 presents, three dimensional idealized geometries and
Newtonian models investigations [66, 67, 26, 68, 52, 69, 70]. In this respect, it is common
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to find that by using a cosine function researches take advantage of the axisymmetry to
explore three dimensional haemodynamics effects.
Non-Newtonian viscosity effects on idealized geometries, have been implemented by
[25, 71, 51]. Finally on the realistic geometries some works can be found, where the
geometry of the vessel was extracted using Magnetic Resonance (MRI) [72, 73]. As far
as the author of this thesis is aware, the work presented in this Chapter is the only one so
far, considering a realistic geometry and including three dimensional effects[3].
Non-Newtonian investigations on realistic geometries, including two or three dimen-
sional effects have been found so far.
3.4 Fluid mechanics of induced stenoses in live mice us-
ing an approximated geometry
This section presents a first approximation to the stenosis geometry observed in Section
2.2. Section 3.4.1 presents the method for obtaining the approximate geometry which is a
simple subjective drawing in three dimensions. Section3.4.2 then present computational
fluid dynamic simulations of this approximate geometry to find the order of magnitude
values of the various fluid stresses that might be expected. A Newtonian and two Non-
Newtonian models are implemented for comparison purposes.
3.4.1 Generation of the approximate geometry of the induced steno-
sis
In order to have a first approximation of the haemodynamics in the described in-vivo
experiment, a stenosis case with an approximated geometry from the experiment was
modeled. The geometry of the blood vessel was modelled with Solid-Works v. 2004
(Solid-Works Corp.) using the integrated tool “loft“ which enable to construct 3D vol-
umes from different cross sections, see Figure 3.3. Some authors have applied a similar
method of drawing in 3D an approximated model, with the aim of get the order of mag-
nitude of the variables[74].
The initial diameter of the cylinder was 42 µm. Based on the in-vivo experiments from
video (sec. 2.2) different cross sectional areas were drawn to perform the loft operations
into the software, assuming that the diameter of the needle that deformed the vessel was
similar in size to the artery (42 µm). Hexahedral elements were used to ensure smooth
streamlines in the subsequent computational fluid dynamics simulations. To ensure suf-
ficient resolution in the discretization, the volume of the fluid was split into five regions
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a)
Initial Length    =  42 µm
Compressed     =  5.69 µm
% of occlusion =  86 %
% Stenosis. Linear 
Initial Area        =  1385 µm
Compressed     =  576 µm
% of occlusion =  60 %
% Stenosis. Area
2
v1
v2
v3
v4
v5
4
2
 µ
m
b)
c) 2
Figure 3.3: Approximated geometry of the stenosis modelled into a 3D software (Solid-Works)
using based on different cross-section areas. a) The volume of control under study was divided in
5 sub-volumes to facilitate the construction of a mesh with hexahedral 3D elements. b) Section of
the compression or stenosis. c) Lateral view of the vessel modelled.
before building a mesh of hexaedrals. The total volume was composed of a core volume
and four volumes around the core (See Fig. 3.3). These five volumes represent the vol-
ume of control of the fluid flow inside the blood vessel to analyse. No elastic effects were
considered, therefore the perimeter of the transversal section undeformed and deformed
was kept constant (131µm). Care was taken to produce a linear stenosis of bigger than
85%. The stenosis with respect the area resulted in a 60%. We transferred the geometry
into a specialized preprocessing grid generation (Fluent, Gambit) to generate a structured
mesh of 76,800 elements.
3.4.2 Computational fluid dynamic analysis of the approximate steno-
sis geometry
To gain insight into the relationship between localised flow changes and platelet aggre-
gation we performed computational fluid dynamic (CFD) modeling of the approximated
stenosed vessel geometry. A finite volume scheme using the commercial software (FLU-
ENT 6.0, Fluent USA, Lebanon, NH) was used to solve numerically the Navier-Stokes
equations 3.1 and 3.2.
∇ · ~u = 0 (3.1)
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ρ[
∂~u
∂t
+ ~u · ∇~u] = −~∇P + µ∇2~u (3.2)
Where ~u represents the velocity vector, ρ represents the density, P the pressure, µ the
fluid viscosity.
On the other hand it is common to get insight about the regime of the flow whether is
laminar or turbulent the Reynolds number can be used and is defined as:
Re =
ρUl
µ
(3.3)
where l is the characteristic length, which in this case is the diameter of the micro-bead,
U the mean fluid velocity. For micro-flows usually the characteristic length is short and
the velocities low, this results in a low Reynolds number which means that the viscous
forces are dominant.
Medium of fluid dynamics model
Blood is composed of both a fluid phase and solid cells of different sizes, and can therefore
it can be classified as a non-homogeneous fluid. This non-homogeneity produce some
non-Newtonian effects. The most common is produced when high shear rates aligns the
cells along streamlines of the flow decreasing the viscosity. Therefore blood viscosity
decreases with increasing shear rates. For the present simulation, the fluid medium was
considered homogeneous with a constant density (ρ = 998.2 kg
m3
) and since blood flow
can be approximated as a Newtonian fluid (constant viscosity) at mid and high strain-
rates[75], the viscosity was set as µ = 0.00348Pas. However for comparison purposes,
some Non-Newtonian viscosity models will be used in this first section as follows:
Carreau model[75]:
µ = µ∞ + (µ0 − µ∞)[1 + (λγ˙)2]n−12 (3.4)
where λ = 3.313 s, n = 0.3568, µ0 = 0.056 Pa s, µ∞ = 0.00345 Pa s.
Power Law model[76, 77, 78]:
µ = 0.1 λ∗ γ˙n∗−1 (3.5)
where
λ∗ = µ∞ + δµ exp[−(1 + γ˙
a
)exp(
−b
γ˙
)] (3.6)
and
n∗ = n∞ + δn exp[−(1 + γ˙
c
)exp(
−d
γ˙
)] (3.7)
where µ∞ = 0.035, n∞ = 1.0, δµ = 0.25, δn = 0.45, a = 50, b = 3, c = 50, d = 4
according to Walburn[79].
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Boundary conditions of fluid dynamics model
In order to solve the Navier Stokes equations numerically, a set of boundary conditions
needs to be specified for every surface of the model (walls, inlet and outlet surfaces).
Therefore it is needed to estimate the amount of flow that is entering the vessel at the inlet
(upstream stenosis), to calculate the shear rate. The blood vessel can be considered as a
capillary tube or radius R and length L. In order to calculate the shear rate in function of
the flow rate some assumptions need to be taken as follows:
1. The flow is fully developed, steady, isothermal and laminar.
2. There is no velocity in the radial direction.
3. No slip at the walls.
4. The flow is incompressible with viscosity independent of pressure.
The shear rate for a fluid flowing between two parallel plates, one moving at a constant
speed and the other one stationary, is defined by:
γ˙ =
v
h
(3.8)
where γ˙ is the shear rate, v is the velocity and h the distance between two parallel plates,
measured in meters. According to [80] the shear rates at the inner wall of a Newtonian
fluid flowing within a vessel is
γ˙ =
8v
d
(3.9)
The average linear velocity v is related to the volumetric flow rate Q by
v =
Q
A
(3.10)
where A is the cross-sectional area of the vessel of radius r given by:
A = pir2 (3.11)
producing:
v =
Q
pir2
(3.12)
substituting velocity in the equation of shear-rate (Eq.3.9):
γ˙ =
8v
d
=
8( Q
pir2
)
2r
(3.13)
which simplifies to the common expression for Newtonian models of fluids on cylin-
ders 3.14,
γ˙ =
4Q
piR3
(3.14)
Since blood flowing in capillary vessels experiences shear-rates (γ˙) between 500 s−1
to 5000 s−1[81], the flow rate (Q) was calculated to produce a shear-rate of 1800 s−1.
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In equation (3.14), γ˙ represents the shear-rate, Q the flow rate, and R the radius of the
cylinder. Using equation (3.14), we calculate that [0.79 µL/min] of fluid flowing in a
vessel of 42 µm, produce 1800 s−1 of shear-rate, corresponding to a Reynolds number of
0.09 upstream of the stenosis. Once the flow rate was known, the developed flow velocity
distribution can be described using the Hagen-Poiseuille equation (3.15),
Vz =
2Q
A
(1− r
2
R2
) (3.15)
Where A represents the area of the cylinder and r is the radial distance from the center of
the cylinder. Equation (3.15) was used as a boundary condition for the inlet velocity. The
boundary condition at the walls was set as zero velocity to enforce the no slip condition.
The boundary condition at the outlet surface was a relative pressure of zero (Pa).
Fluid Velocity and Viscous Stress
If the velocity profile is known it is possible then to calculate the deformation rates that
fluid elements and particles transported by the fluid experience. Once the deformation
rates are known, these deformation rates along with viscosity value can be used to calcu-
late the viscous stress produced by the fluid flow. Since fluid deformation rates and stress
related quantities are commonly used but often confused, this section will present some
basic concepts for convenience to the reader as well as some terms and concepts that will
be used for the following sections.
The velocity in its vectorial form of fluid elements can be expressed as
~u = u1~i+ u2~j + u3~k (3.16)
In a general case each component can be a function of x, y, and z. For fluids in constant
motion as is the case of the present investigation, it is preferable to describe the motion
and deformation of fluid elements in terms of rates. In order for these deformation rates
to be useful they should be expressed in terms of derivatives of velocity. The velocity
gradient tensor contains all the derivatives of each velocity component, and it can be
expressed in function of a deformation tensor and a rigid body rotation tensor as:
∇~u = ∂ui
∂xj
= ˙ij + ωij (3.17)
The rigid body rotation tensor (ωij) is anstisymetric and relates to the vorticity. On the
other hand, the deformation tensor (˙ij) is symmetric and relates to the viscous stress that
fluid elements and particles experience due to the fluid motion. This deformation tensor is
also known as strain-rate tensor and is of main interest for the present investigation. This
tensor can be expressed as:
˙ij =
1
2
(∇u+∇uT ) = 1
2
(
∂ui
∂xj
+
∂uj
∂xi
) (3.18)
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Or in its expanded form:
˙ij =
 ˙11 ˙12 ˙13˙21 ˙22 ˙23
˙31 ˙13 ˙33
 =
 ˙xx ˙xy ˙xz˙yx ˙yy ˙yz
˙zx ˙zy ˙zz

In cartesian coordinates::
˙ij =

∂u
∂x
1
2
(∂u
∂y
+ ∂v
∂x
) 1
2
(∂u
∂z
+ ∂w
∂x
)
1
2
( ∂v
∂x
+ ∂u
∂y
) ∂v
∂y
1
2
(∂v
∂z
+ ∂w
∂y
)
1
2
(∂w
∂x
+ ∂u
∂z
) 1
2
(∂w
∂y
+ ∂v
∂z
) ∂w
∂z

Since this is a second order tensor, a scalar quantity obtained from its components rep-
resents the magnitude of the deformation rates as a consequence of the fluid movement.
The scalar commonly used to represent the magnitude of the total deformation rates of the
fluid is known as the second invariant of the strain-rate tensor, which is a mathematical
operation that includes any possible contribution of the extensional and shear strain-rates.
The second invariant (J2) of the strain-rate tensor is defined as:
J2 = [
1
2
(˙ij ˙ij − ˙ii˙jj)] 12 (3.19)
and it can be written as:
J2 = (
1
6
[(˙xx − ˙yy)2 + (˙yy − ˙zz)2 + (˙xx − ˙zz)2] + ˙2xy + ˙2yz + ˙2xz)
1
2 (3.20)
Where ˙xy,˙yz,˙xz, are the components of shear strain-rate (s−1), and ˙xx,˙yy,˙zz, the
components of extensional strain-rate (s−1) [82]. For the case of unidirectional flow when
there are just shear strain-rate components is common to refer to the quantity obtained
from J2 as just shear-rates (like Couette cells and capillary channels), however when the
fluid experiences acceleration/deceleration in the flow direction, the extensional strain-
rate components are also present together with the shear strain-rate components and the
quantity obtained from J2 will be referred just as strain-rates.
Furthermore the viscous stress of a fluid can be calculated using the strain-rate tensor
and the fluid viscosity (Pa s). If a Newtonian fluid is considered, then the stress tensor is
linearly proportional to the strain-rate tensor. This assumes that the viscosity is constant.
It can be show[83] that the viscous stress tensor reduces to
τij = 2µ ˙ij (3.21)
However since most of research done on blood has been refers to the shear or strain
rates, in order to facilitate the comparison, all the calculation in this work will be presented
as a function of the strain-rates (s−1) instead of the stress (Pa). Therefore in the following
sections any strain-rate quantity referred will mean that is has shear and extensional strain-
rate components, and it should be reminded that it is closely related to the viscous stress
according to Equation 3.21.
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Results of first approximated geometry
CFD modeling of the in vivo vessel geometry predicted a laminar flow regime, no recircu-
lation, and blood strain-rates ˙ ≤ 20000s−1 at the stenosis apex that rapidly transitioned
to 1862s−1 within the post-stenosis expansion zone (Fig. 3.4).
a)
b)
Figure 3.4: Haemodynamics on approximated model constructed using a 3D modeler (Solid-
Works) and a hexahedral mesh. a)Strain-rates on approximated model at 60% stenosis (area)
and 85% stenosis (linear) ( see Fig.3.3) b)Streamlines showing laminar flow and no-recirculation
conditions.
Fig. 3.5 presents the strain-rate history for a particle travelling at 1µmm from the wall
calculated using a Newtonian, a Power Law and a Carreau model. It can be observed
that at this Reynolds number the the strain-rates are high, therefore the assumption of
Newtonian viscosity is valid.
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Figure 3.5: Comparison of a Newtonian, Carreau and Power Law viscosity models on approxi-
mated mouse geometry model at Re 0.09. Observe that all models produce similar calculations
therefore, the assumption of Newtonian viscosity is valid.
In order to explore if our Non-Newtonian model could represent any Non-Newtonian
effect, the Reynolds number was changed. Fig. 3.6 presents the dimensionless velocity
profiles calculated at different Reynolds numbers, compared with a model of constant
viscosity (Newtonian fluid). The figure shows that the model works as expected, as the
velocity profile is blunted at low strain-rates (much lower Reynolds number). It can be
observed that at this Reynolds number, the strain-rates are high. Therefore the assumption
of Newtonian viscosity is valid.
Linking this simulation with the in-vivo experiment result, it can be suggested that a
zone of where the strain-rates are increasing followed by a zone where the strain-rates
are decreasing (called shear micro-gradient) may be a requirement for the development of
discoid platelet aggregates (Fig. 3.4). The name of shear micro-gradient was suggested
as a need to differentiate this environment of dynamic deformation from the commonly
used deformation in blood research (constant shear) although strictly speaking the history
of deformation contains not only shear but also extensional components. On the other
hand it is deformation rates occurring in a micron-scale. Using this model it was possible
to identify three principal components defining a shear micro-gradient or stenosis, the
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Figure 3.6: Comparison of dimensionless velocity profiles for a Newtonian viscosity model and
a Power Law at different Reynolds number. Observe that at the Reynolds number of the experi-
ment, the velocity profile using a non-Newtonian viscosity model is similar to the profile using a
Newtonian viscosity model, therefore the assumption of Newtonian viscosity is valid.
contraction region which demarcates the acceleration, the throat or apex demarcates the
stenotic region where a peak strain-rate is experienced and the expansion that demarcates
a decrease in the strain-rates. It can be concluded from this section that micro scale
stenosis produce sudden increases/decreases in the flow strain-rate in the micron scale
(micro-gradients). Since the accepted chemical factors driving platelet activation were
blocked in the mouse experiment, and no recirculation zones were found, it is suggested
that platelet formation is likely driven primarily by haemodynamics forces occurring in
regions of laminar flow. It was observed that a Newtonian viscosity model behaves in the
same way that more complex models of viscosity due the high strain-rate regime of the
experiment.
This approximate stenosis geometry was subjectively constructed to experience a fixed
stenosis (85% linear and with respect the area 60%). The amounts of vessel contraction
impact directly on the maximum strain-rates experienced. The desire to explore slightly
different scenarios of contraction with consistency in the geometry shape across each
one makes the present method of modelling unreliable, and demands for a more realistic
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modelling to obtain the geometry of the deformed shape.
3.5 Fluid mechanics of induced stenoses using a mecha-
nistic model
In the modelling of the first geometry important aspects of the deformation process were
neglected, which resulted in a model that likely overlooked subtle, but important aspects
determining the platelet aggregation. On the considerations taken we can include the
local angles of the geometry, the amount of vessel occlusion, and the shape of the cross
sectional area, which was the most subjective parameter, since it is impossible to precisely
determine the cross sectional shape from the view that the footage was taken. It was also
desired to quantitatively explore different degrees of stenosis (50%,70% or 90%), with
consistency in the deformation history. It was not feasible to use the subjective approach
of Section 3.4 to obtain such quantitative data. A more precise method was thus developed
where the geometry of the deformed vessel was generated by producing a realistic model
of the arteriole-needle interaction with the mechanical properties.
This section presents a more precise approach to analyzing the geometry of the in-
duced stenosis observed in Section 2.3. Section 3.5.1 presents an analysis of video ob-
servations of induced stenosis in mice to provide a benchmark for the stenosis models.
Section 3.5.2 presents the implementation of a finite element analysis to simulate the me-
chanical response of the artery. Section 3.5.3 presents the results of the finite element
simulation. Section 3.5.4 presents the calculation of the haemodynamics from the ge-
ometry generated in Section 3.5.3. Section 3.5.5 presents the relationship between the
peak strain-rate, degree of stenosis and arteriole wall elasticity. A similar relationship is
presented in Section 3.5.6 but in terms of strain-rate distribution using contour plots. Sec-
tion 3.5.7 presents the strain-rate history for specific streamlines of interest. Section 3.5.8
presents the role of the needle diameter. Section 3.6 presents a comparison of the stenosis
model generated using the mechanistic model geometry and canonical stenosis models
used by other researches. Finally the conclusions are summarized in Section 3.8.
3.5.1 Video images of artery wall deformation
To obtain a more detailed description of the artery wall response, a set of experiments were
performed on arteriole stenosis by compressing arterioles (blood vessels with diameter
90µm-120µm) with blunted needles of different diameter from (10µm-20µm) to (90µm-
120µm) according to a modified method previously published [1]. Experiments were
recorded by DIC microscopy using a Leica DMIRB inverted microscope (40×).
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Figure 3.7: Induced stenosis in-vivo using a micro-needle and observed under the microscope at
40×.
Figure 3.7 presents a selection of images recorded during this investigation. Further
clear images were obtained of the whole deformation history, which will enable to com-
pare graphically with the simulations of the finite element analysis. These images will be
used as a benchmark for comparison in the following sections.
3.5.2 Mechanistic generation of the geometry of the induced stenosis
To obtain a precise model of the geometry of an arteriole deformed using a blunted needle
as presented in Section 3.5.1, finite element analysis of the mechanical structure was
performed.
Geometry of the finite element analysis
A section of biological tissue (composed by the artery and lipid tissue) was considered
mechanically as a cylindrical tube undergoing bending deformation. Blood vessels re-
ceive some perivascular constraint from the surrounding tissues [84]. During the devel-
opment of the simulations, it was observed that lipid tissue, although being less rigid than
an arteriole, plays a significant role in defining the local shape of the artery in contact
with the needle. Figure 3.8 presents an illustration of the model. The soft lipid tissue
was modelled as a cylinder with an external diameter of 500µm and an internal diameter
of 110µm. The arteriole was then modelled within this lipid tissue as a hollow cylinder
with outer diameter of 110µm and inner diameter 100µm, therefore the thickness of the
artery wall was 10µm, which was modelled as a single layer. The model was discretized
with hexahedral low order elements of 8 nodes, using Ansys v12.0. (Ansys Corportation,
Houston PA).
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lipid tissue  φ 500µm 
isotropic linear
arteriole φ 100µm 
hyperelastic
a) b)
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selected
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Figure 3.8: Schematic of the in-vivo experiment and its discretization in finite elements. A micro
needle deforms an arteriole to reduce the cross sectional area. a) Needle tip and biological tissue
(artery + soft tissue) modelled. b) Discretization in finite elements of the biological system and
the needle head.
Material properties of the structural model
In order to model the mechanical deformation of the biological system a hyper elastic
constitutive model was used. Although the arterial wall is known to have heterogeneous
and anisotropic structure owing to multiple compositions including collagen, elastin and
muscle fibers [85], a classical isotropic Mooney-Rivlin model was employed for the arte-
riole. Two different set of mechanical properties for the carotid artery wall can be found
in the literature [86, 87]. Finite element analysis was conducted using both of these sets
to investigate the significance the artery elasticity on the resulting geometry. Table 3.2
presents a summary of the material parameters used in our model.
Boundary conditions of the structural model
From the in-vivo experiments, it was observed that regions of the artery far from the
deformation zone experience almost zero or no-movement. Therefore all the degrees of
freedom of the nodes representing the extremes of the biological tissue model were set
to zero. The movement of the needle was modelled by imposing a boundary condition
of displacement to all the nodes of the needle of 2.5 artery diameters in the vertical axis
(y axis). According to the in-vivo experimental observations of Section 3.5.1, the needle
is able to break just the soft tissue surrounding the artery, however the artery undergoes
deformation under contact by the needle tip. This arteriole wall-needle interaction was
modelled was modeled using contact elements.
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Table 3.2: Mechanical properties used for the biological tissue modelled as solid hyperelastic. W
is the strain energy function, ~I1, ~I2, ~I3, ~I4, ~I5, are the strain invariants, and J is the local volume
ratio. C10, C01, C20, C11, C02, and d are material parameters. E is the Elastic modulus, ν is
the Poisson ratio, ρ is the material density. The lipid tissue and needle were modeled as a linear
isotropic.
Material Model used Constants
Arteriole[86, 88]Elasticity 1
W = C10(~I1 − 3) + C01(~I2 − 3) + .. C10 = 2.67× 103[Pa]
..+ 1d(J − 1) C01 = 8.365[Pa]
d = 4× 10−6
Arteriole[87]Elasticity 2
C10 = 5.04× 104[Pa]
C01 = 3.05× 104[Pa]
W = C10(~I1 − 3) + C01(~I2 − 3) + .. C20 = 4× 104[Pa]
C20(~I3 − 3) + C11(~I4 − 3) + C02(~I5 − 3) + .. C11 = 1.25× 104
1
d(J − 1) C02 = 1× 104[Pa]
d = 4× 10−6
Lipid tissue[87]
E = 1× 103[Pa]
Linear isotropic ρ = 998 kg
m3
ν = 0.499
Needle head
E = 1× 109[Pa]
Linear isotropic ρ = 7800 kg
m3
ν = 0.333
Solution of the structural model
A non linear solution with a sequential algorithm solver was used, with a variable load
step in function of the material and mesh size, varying from 50 to 1000 steps. Since
the hyper elastic material is assumed incompressible and may lead to numerical errors
(volumetric mesh locking, or inaccuracy), a uniform reduced integration with mixed uP
element formulation was used. This formulation uses not only displacement (u) but also
hydrostatic pressure (P) as primary unknown variable. Mesh convergence was obtained
after observing no variation in the displacements bigger than 5%, although a finer mesh
was used to have a better description of the deformed wall artery.
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3.5.3 Results of the mechanistic model of the stenosis geometry and
comparison to the experimental observations
The results of the mechanistic model are presented in Figure 3.9. In order to validate
the numerical simulation of the biological tissue elastic response a qualitative comparison
between the shape of the deformed wall obtained numerically and the experimentally ob-
served in-vivo case at different needle displacements was performed. Figure 3.9a) shows
selected images of the in-vivo experiment described in Section 3.5.1. These correspond
to approximately 20%, 50%, 70%, 80%, and 90% area reduction from the undeformed
case. Figure 3.9b) presents a 2D cross-section of the mechanistic model corresponding
to similar degree of stenosis with the two set of different artery wall elasticities defined
in Table 3.2. In Figure 3.9c) these two mechanistic simulation results are overlaid on
the video images to enable qualitative comparison of the location of the artery walls. In
general, good qualitative agreement is evident in each case, and it is evident that the sim-
ulation is sensitive enough to show small differences in the deformed shape, produced by
different elasticities.
Role of needle displacement and wall elasticity on cross sectional area
Since the algorithm used to solve the structural model was sequential (i.e the total dis-
placement of the needle was imposed progressively, in a similar way that the in-vivo
experiment was performed), a quantitative history of the elastic deformation of the artery
was obtained. From the structural simulation it was possible to precisely calculate the
cross sectional area in the contraction and obtain a precise relation between the needle
displacement and the fraction of area reduction, as is shown in Figure 3.10a). Since the
whole biological tissue can move relatively freely when is in contact with the needle until
some point, the reduction of the area in the artery starts when the needle displacement is
around 60µm. This is a result of the low restrained model and occurs in a similar way in
the experiments.
In a more elastic tissue more needle displacement is needed to produce an equiva-
lent tissue deformation than is required for a less elastic tissue for the same equivalent
cross sectional area. Figure 3.10b), shows the geometric cross section of the vessel for a
range of percentage area reductions with respect the original area, for two different artery
elasticities. In a more elastic tissue (Elasticity 1) the bottom wall tends to take the shape
of the needle tip, contrary to a less elastic tissue where both walls tend to move with a
similar displacement. From the results of Figure 3.9 and Figure 3.10 it is evident that
the mechanistic approach provide a detailed geometry which qualitatively matches the
artery deformation observed for the in-vivo experiment described in Section 3.5.1. Hav-
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Figure 3.9: In-vivo experiments and simulations of needle-arteriole interaction. a) In-vivo steno-
sis at different percentages of area reduction. b) Numerical simulation of in-vivo stenosis at the
correspondent stages of stenosis for two different elasticities defined in Table 3.2. c) Qualitative
validation of the simulations by overlapping the in-vivo cases and the numerical results.
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Figure 3.10: Role of the position of the needle on the cross sectional area and maximum strain-
rate. a) Area reduction vs needle displacement. b) A ea reduction shapes for two different material
properties defined in Table 3.2.
ing confirmed that a precise model of the deformed blood vessel can be achieved using
mechanistic modelling, it is now possible to use these precise geometric models to simu-
late the haemodynamics with in these geometries along the whole deformation history of
the artery wall. It should also be noted that Figure 3.9 exhibited significant differences in
local geometry, when a different artery wall elasticity is used. It would be informative as
well to study the impact of these geometrical differences in the context of haemodynam-
ics.
3.5.4 Computational Fluid Dynamics analysis of the mechanistically
modelled stenosis geometry
Having shown in Section 3.5.3 that a mechanistic model of the deformed arteriole can
produce qualitatively similar geometries to those observed in the experiments described
in Section 3.5.1, the next step was to solve the equations of fluid flow in the geometries.
Geometry of fluid dynamics model for the induced stenosis
To generate the geometry needed to perform computational fluid dynamic analysis inside
the artery, it was necessary to translate the deformed arteriole model obtained from Sec-
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tion 3.5.2 into a geometry that could be input into the a fluid-solver simulator. Although
there are methods that enable fluid dynamic analysis to be performed in conjunction with
structural simulations (based on Fluid Structure Interaction algorithms), these rely on
automatic mesh generation and this is not a reliable way to produce a good quality dis-
cretization especially when the aspect ratio (average feature size of the model/minimum
feature size of the model) is changing in a very localised region. This is a problem for
the geometries >70% of stenosis. Therefore a method to translate the deformed geom-
etry resulting from the Ansys mechanistic model into a format that could be read by a
specialized software for mesh generation (ICEM or Gambit) was developed. Figure 3.11
presents an illustration of the conversion of the structural model to the fluid dynamics
geometry. For a given substep of the structural solution, points were defined with the
coordinates of the displaced nodes, then lines were constructed connecting these points
sequentially, and areas were constructed within these lines. Finally a volume representing
the volume of control of the fluid inside the artery was constructed with the areas, and
exported as an Initial Graphics Exchange Specification (IGES) file to be read by mesh
generation software. All these tasks were written in a APDL (Ansys Parametric Design
Language) script. Once the solid volume was constructed the cross-sectional area in the
narrowest region of the contraction was measured and the stenosis was determined as a
percentage of the occluded area with reference to the original undeformed case. Five cases
were selected to conduct the haemodynamics study. These were cases with area reduction
of 20%, 50%, 70%, 80%, and 90%. The geometries were discretized with hexahedrals
using ICEM (Ansys).
Medium of fluid dynamics model
The same fluid medium used in Section 3.5.4 was used. Therefore a Newtonian fluid was
considered with a density (ρ = 998.2 kg
m3
) and a viscosity of (µ = 0.00348Pas), since
blood can be approximated as a Newtonian fluid if the strain-rates are high[75].
Boundary conditions of fluid dynamics model
The same methodology described in Section 3.5.4 was applied to calculate the inlet
boundary condition. Using Equation (3.14), it was found that a flow rate ofQ = 10.6[µL/min]
of fluid flowing in a vessel with diameter of φ = 100µm, produces a shear-rate at the wall
of 1800s−1, corresponding to a Reynolds number of Re=0.51 upstream of the stenosis.
The main difference in the boundary conditions compared with the Section 3.5.4, is that
in the current model, the flow rate was adjusted according to the degree of stenosis. Ob-
servations of flow in coronary arteries[2, 89, 90] suggest that a high degree of stenosis
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b.3) Lines generated from points
b.3) Areas generated from lines
b.4) Volume generated and exported
c) CFD mesh composed by hexaedrals generated  from volume
Arteriole
Needle
a) Structural solution
b) Generation of the geometry of the deformed artery to perform fluid analysis.
b.1) Nodes from arteriole  wall converted into points
Figure 3.11: Generation of the geometry to perform haemodynamics analysis. a) Structural solu-
tion at a given substep of the solution. b) Steps followed in the reconstruction. b.1) Points were
defined with the coordinates of the displaced nodes. b.2) Lines were generated from the points.
b.3) Areas were generated filling the constructed lines. b.4) A volume of control representing the
fluid flow inside the artery. c) A CFD mesh suitable for haemodynamics analyses can be generated
from the volume reconstructed.
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Figure 3.12: Decrease of flow rate as function of stenosis. Taken from [2]
increases the resistance of the vessel, producing a decrease in the flow rate. According to
Figure 3.12, the drop in flow rate was considered as being a 25% of drop of flow rate at
80% of stenosis and a 65% of drop of flow rate at 90% of stenosis[2, 89].
The boundary condition at the walls was set as zero velocity to enforce the no slip
condition.
Solution of fluid dynamics model
A finite volume scheme using the commercial software (FLUENT 6.0, Fluent USA,
Lebanon, NH) was used to solve numerically the Navier-Stokes Equation 3.1 and Equa-
tion 3.2, described in Section 3.4.2. The haemodynamics computation was carried out
assuming steady state laminar flow. The vessel wall was assumed to be rigid since mini-
mal deformation due to the pulsatile flow has been observed for these arterioles. A mesh
convergence analysis was conducted by increasing the number of nodes and calculating
the maximum strain-rate predicted. Figure 3.13 shows the percentage difference between
the maximum strain-rate calculated between subsequent refinements as a function of the
number of nodes. Plots are shown for area reductions of 80% and 90% and with the ar-
teriole wall elasticity set to Elasticity 1 and Elasticity 2, as defined in Table 3.2. Mesh
convergence was assumed after observing variation in the maximum strain-rate values
less than 5%.
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Elasticity 1 90%
Elasticity 1 80%
Elasticity 2 90%
Elasticity 2 80%
Figure 3.13: Mesh Convergence of 80% and 90% cases.
3.5.5 Relationship between peak strain-rate and degree of stenosis
and arteriole wall elasti ity.
Having translated the mechanistic model such that it can be used for computational fluid
dynamic analysis and having ensured the mesh is of sufficient quality, it is now possible
to explore the fluid dynamic conditions that can be expected in the stenosis geometry. The
first investigation explored the relationship between the maximum strain-rate experienced
by the fluid and the degree of area reduction. Figure 3.14 shows a relationship between
maximum strain-rates predicted by computational fluid dynamics as a function of area
reduction for the geometries and two different wall elasticities as defined in Table 3.2.
A non-linear relationship is evident. The maximum flow strain-rates predicted on both
wall elasticities is on the same order of magnitude, being different by less than 15%.
Figure 3.14 shows that 80% and 90% stenoses can increase the strain-rate by a factor of 35
and 45 times the strain-rate of the undeformed vessel (from γ˙ = 1800s−1 to γ˙ = 60000s−1
or γ˙ = 85000s−1).
The shear equation for a rectangular section is given by [91] and was used to compare
the maximum strain rate at different cases of stenosis, with the numerical model.
γ˙ =
6Q
w h2
(3.22)
where γ˙ represents the shear-rate,Q the flow rate,w the width and h the height (w << h).
Although the material properties of the arteriole wall are significantly different between
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Figure 3.14: Maximum fluid strain-rates obtained along the artery-needle deformation process
for two different artery wall mechanical properties. The strain-rates for a rectangular section
calculated using Eq.3.22 are also presented for comparison.
the models, the peak strain-rate obtained by deforming with a needle to a specific de-
gree of stenosis with respect the area, resulted in approximately the same peak strain-rate.
For cylinders of regular geometry, the shear-rate is proportional to flow rate but inversely
proportional to the cube of the diameter (Eq. 3.14). For a rectangular section when the
height is much smaller than the width (h  w), Eq. 3.22 is used. Figure 3.14 shows the
calculated strain-rates approximating the vessel cross-section as rectangular and assum-
ing that the perimeter of the cross-section remains constant. The numerical calculations
follow the same trend as Eq. 3.22, but departs from this relationship at between 50-90%
area reduction. The higher strain-rates predicted by the numerical model are due mainly
to local protrusio s in the geometry. For extreme cases of stenosis (90%) both, Eq. 3.22
and the numerical model showed good agreement.
If peak strain-rate were the only important parameter defining the platelet aggregation
then it might be predicted that both artificial stenoses would produce the same aggrega-
tion response regardless of wall elasticity and local differences of geometry. It is hypothe-
sised, however, that along with the peak strain-rate the strain-rate experienced before and
after that peak (strain-rate history) of given platelet at a specific stenosis is also an im-
portant factor in determining how a particular stenosis will induce aggregation. In order
to explore this hypothesis, a more thorough investigation of the strain-rates predicted by
the computational fluid dynamics was conducted, with particular emphasis on studying
changes of strain-rate along the direction of flow.
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3.5.6 Relationship between strain-rate distribution, degree of steno-
sis and arteriole wall elasticity.
Having established a quantitative relationship between the maximum strain-rate, the nee-
dle displacement and degree of stenoses, we proceed to explore in detail changes in the
strain-rate along the direction of the flow that would be experienced by platelets passing
through the mechanistically modelled stenoses. To visualize the strain-rate distribution,
Figure 3.15 presents a sequence of contour plots of the strain-rates contour plots for Elas-
ticity 1 and Elasticity 2 defined in Table 3.2, and for stenosis area reductions of 50%,
70%, 80% and 90%. Each element of Figure 3.15 presents a longitudinal cross-section
(cut along the direction of flow) and a lateral cross-section (cut at the location of peak
strain-rate). It should be noted that the location of peak strain-rate is in the center for the
cases with Elasticity 2, but is at the circumference of the needle for Elasticity 1.
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Figure 3.15: Strain-rates contour maps of the deformed arteriole. Longitudinal and cross sectional
view over different degree of stenosis, and two arteriole elasticities defined in Table 3.2.
The observed difference in the location of peak strain-rate is due to the more elastic
case (Elasticity 1) being able to adapt to the shape of the needle head, forming significant
protrusions corresponding to the circumferences of the needle aperture, which lead to
localised changes in the local velocity producing high strain-rates zones (red zones), con-
trary to the less elastic case (Elasticity 2), where the deformation is more homogeneous
therefore velocity does not change as abruptly and the strain-rate distribution presents
more gradual changes. As the strain-rate measures the magnitude of the spatial changes
in velocity (as explained in Section 3.4.2), the more elastic case (Elasticity 1) presents
higher strain-rates for the same amount of area reduction than the less elastic case (Elas-
ticity 2). It can be observed that the interaction between the needle and the artery wall in
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contact determines the local shape of the deformation, impacting locally in the haemody-
namics strain-rate distribution. This analysis demonstrates that the geometry imposed by
the needle can have a significant effect on the distribution of the strain-rates and its rate
of change along the trajectory of flow.
Evidently the elasticity of the artery wall has a significant impact on the shape of the
stenosis along the direction of flow and consequently significantly impacts the strain-rate
history that will be experienced by the platelets. If it is true that the strain-rate history
is a major factor in the initiation of aggregation, then these two cases should behave
quite differently. To explore the differences between the strain-rate histories that might
be experienced by a platelet flowing through each stenosis a more detailed investigation
of the strain-rates experienced along specific streamlines was conducted.
3.5.7 Strain-rate history predicted along streamlines
The previous section provided quantitative evidence that when arterioles of different wall
elasticities are stenosed to the same area reduction they will produce similar peak strain-
rate conductions, but may produced significantly different distribution of strain-rates in
the regions close to the stenosis. This section aims to quantify the effect that these dif-
ferences in shape cause in the strain-rates experienced by a platelet passing through the
stenosis.
In order to gain a more accurate comparison into the effect of changing wall geometry on
the strain-rate experienced by blood cells, the strain-rate histories of streamlines which
pass 1 µm of the vessel wall at the contraction were studied. Since platelet concentration
in blood flow is greatest near the vessel wall [92, 93, 94, 95, 96], streamline trajectories
within 1µm from the wall at the contraction (maximum strain-rate zone) were selected.
Figure 3.16a) presents a comparison of the selected streamlines which pass within within
1µm of the wall at the location of the stenosis extracted from the computational fluid
dynamics of the geometry with 80% degree of stenosis for both cases arteriole wall Elas-
ticity 1 and Elasticity 2. These streamlines are coloured according to the velocity of the
particles travelling along this streamline. It is evident that not only is the path taken by a
platelet different in these two cases, but the platelet will also experience a different veloc-
ity, acceleration and deceleration as it follows this streamline, therefore it will be subject
to different forces along the streamline.
Figure 3.16b) presents the velocity experienced by a fluid particle travelling along the
streamlines depicted in Figure 3.16a), as function of distance. The peak velocity achieved
is similar in both cases of arteriole wall Elasticity, but the acceleration and deceleration
are far more rapid in the case of Elasticity 1 than for Elasticity 2. Figure 3.16c), presents
the strain-rate calculated from these velocities. The origins of these streamlines have been
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Figure 3.16: Streamline histories of selected stenosis. a) Selected streamlines. b) Velocity ex-
perienced by a particle following a streamline 1µm from the wall. c) Strain-rate histories for the
selected streamlines aligned to compare the deceleration zone.
offset to the point of maximum strain-rate enable comparison of the deceleration. It can
be observed that the overall velocity and strain-rate are in the same order of magnitude
however, significative differences exist along the trajectory, in the scale of the platelet size
(2µm). Significantly, in the case of Elasticity 1 the strain-rate drops far more rapidly than
Elasticity 2 when leaving the stenosis.
If it is true that platelet aggregation response is determined not only by peak strain-rate,
but also by strain-rate history outside of the stenosis region, then different aggregation
responses might be expected for similar degrees of stenosis applied to arteries of different
elasticity.
3.5.8 Role of Artery/Needle diameter ratio on duration of maximum
strain-rate
In the previous investigation it was shown that the elasticity of the artery wall could sig-
nificantly vary the strain-rate experienced by a platelet flowing in close proximity to the
wall. It is true that the elasticity of the artery wall may vary from experiment to experi-
ment, but this is a very difficult quantity to control. There are however other variables that
could be controlled when inducing an artificial stenosis on a mouse artery. One prominent
experimental variable that could be varied is the diameter of the needle used to produce
the stensosis. This section explores whether changing the diameter of the needle could
produce different strain-rate histories for the same degree of stenosis. The method used
to explore the impact of needle diameter on the fluid mechanics of an artificially induced
stensosis is similar to that used in Sections 3.5.2, but with a needle diameter of 20µm.
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The elasticity of the artery was fixed as Elasticity 2 (Table 3.2) for all investigations.
Figure 3.17, shows a compendium of the results obtained for a needle size of 20µm. Fig-
ure 3.17a shows the comparison with the in-vivo experiment where an arteriole of 100µm
is deformed using a micro needle of 20µm of diameter. Also a comparison of the images
recorded from the in-vivo experiment (as described in Section 3.5.1) and different wall
geometries obtained from the mechanistically simulated arteriole (as described in Sec-
tion 3.5.6) are presented. Good qualitative agreement is evident between the wall loca-
tions in the mechanistic simulation and the images recorded from the in-vivo experiment.
Figure 3.17b), shows the cross sectional area and its calculated strain-rates. It is notice-
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Figure 3.17: Simulations with a smaller needle (20µm). a) Comparison of intra-vital studies and
numerical simulations. b) Strain-rate maps on the cross sectional area c) Streamlines histories. d)
Streamlines histories aligned to study the rate of acceleration/deceleration.
able an increase in the magnitude of the strain-rates is noticable compared to the previous
case of needle diameter 100µm. This can be explained as following, since smaller spatial
changes produce higher changes of velocity, the rate of change of velocity (strain-rate)
is larger. Due to the arteriole/needle ratio, the area occluded at 65% represents the max-
imum occlusion when the lower wall is not in contact yet with the upper wall. For the
100µm a 90% degree of stenosis was possible before the lower and upper walls touched.
Figure 3.17c) shows the comparison of the strain-rate history experienced along a stream-
line located 1µm from the artery wall in the stenosis region, for an equivalent area of 65%
reduction and same elasticity for both (Elasticity 2 in Table 3.2) 20µm and 100µm needle
diameters. Examining these two strain-rate histories it is evident that a similar maximum
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strain-rate is experienced but the length over which this peak strain-rate is distributed is
on the order of 5 times less for the 20µm needle than the 100µm needle. This is not
surprising since the dimensions of the needle tips causing the strain-rate also differ by a
factor of 5. Figure 3.17d) shows the comparison of the strain-rate history presented in
Figure 3.17c) but with the origin of each plot set to the location of peak strain-rates. This
realignment enables comparison of the rate of acceleration/deceleration of the two cases.
It can be observed that the rate of change is similar in both cases. This is in contrast
to the significantly different deceleration rates that were predicted for differing arteriole
wall elasticity as shown in Figure 3.16b). This slope in the velocity therefore depends
closely on the mechanical properties of the artery wall. Therefore from this investigation
it can be concluded that for a given artery changing the needle diameter will change only
the residence time that platelets experience the peak in the strain-rate without impacting
the acceleration/deceleration rate. This ability to isolate these two parameters may be of
interest for future research into mechanical factors influencing platelet aggregation using
live animals.
3.6 Comparison of mechanistically model geometry and
canonical stenosis models
Sections 3.5.7 and 3.5.8 have shown using realistic mechanical modelling and computa-
tional fluid dynamics that significantly different strain-rate histories can result from var-
ious different conditions for artificially induced stenoses. This realistic modelling has
revealed how sensitive the strain-rate environment of a stensosis can be to the various
experimental parameters. Several previous investigations studying the haemodynamics
of a stenosis have assumed that the geometry can be approximated with a cosine func-
tion without a rigorous corroboration [97, 98, 99, 100, 101, 102, 69, 103]. It would be
instructive to compare some of the geometries utilized in previous investigations to the
ones obtained this far in this chapter in order to identify any significant differences. This
section presents a comparison of the mechanistically obtained geometries of Section 3.5.4
and their haemodynamics with a selection of the idealized geometries that can be found
in the literature. From this analysis, differences in the stenosis parameters are pointed out
that may be critical to promote platelet aggregation.
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3.6.1 Canonical stenosis model geometries
To analyse a canonical stenosis model, we utilized a cosine function. The shape of the
contraction takes the form according to the Equation 3.23:
r(z)
R
= 1− δc[1 + cos(Zpi
L
)], −D ≤ Z ≤ D (3.23)
In Equation 3.23, R is the radius of the unstenosed vessel and L is the length of the
stenosis, r and Z are the radial and axial co-ordinates. The parameter δc, that controls the
percentage of the stenosis of area reduction. For this investigation a value of δc = 0.2 was
chosen corresponding to a 80% of stenosis with respect the area. Two different length of
the stenosed zone were used L = 200µm and L = 300µm (L=4R and L=6R), since is the
range of variation utilized by the referred investigations [97, 98, 99, 100, 101, 102, 69].
3.6.2 Haemodynamics of the canonical stenosis model
The Navier-Stokes equations were solved numerically using the same method described
in Section 3.4.2. Figure 3.18 presents the predicted haemodynamics behaviour for the
canonical models with streamlines colored by velocity of the fluid flow. Figure 3.18a)
and b) presents the haemodynamics solution for a cosine-shaped geometry where the
length of the stenosis is L = 200µm and L = 300µm respectively. It was of interest to
compare these geometries to the mechanistic solutions found in Section 3.5.7. To perform
this comparison a streamline was selected located at 1µm at the apex of the contraction.
Figure 3.19 presents the strain-rate calculated using Equation 3.20 for a streamline which
passes 1µm from the wall at the apex of the stenosis. Figure 3.19a) shows the streamlines
with the calculated strain-rate, as a function of length for the canonical cosine geometries
of Figure 3.18. The strain-rate predicted along similar stream lines in the mechanis-
tic models with the two elasticities from Figure 3.16 are also presented for comparison.
Figure 3.19b) shows the strain-rate along the same streamlines as Figure 3.19a) but as a
function of time. It can be observed that the peak strain-rate predicted along the stream-
lines for the cosine shape geometries is significantly lower compared with the mechanisti-
cally modelled needle induced stenosis geometries. This can be explained due to the fact
that the cosine geometries are smoother and the changes produced in the principal direc-
tion of the velocity on these geometries are less abrupt. The strain-rate is related to the
gradient of velocity and thus the smoother cosine shaped geometries produce less changes
in velocity than the more abrupt needle induced stenoses. Figure 3.19c) presents a com-
parison of the deceleration regions of the shear stress profiles of Figure 3.19b) aligned
such that their origins were set at the value of peak shear stress. Figure 3.19d) shows the
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A
Figure 3.18: Haemodynamics comparison of mechanistic model and canonical stenosis model. a)
Streamlines at the middle plane where the maximum velocity is experienced for a cosine shape of
L= 4R (Stenosis of 200 µm). b) Streamlines at the middle plane where the maximum velocity is
experienced for a cosine shape of L= 6R. (Stenosis of 300 µm)
same information as Figure 3.19c) but plotted as a function of time. It can be observed
that in terms of history over length, using a cosine function with length of stenosis of 200
µm (red line) is equivalent to the case of an stenosis with lower elasticity (Elasticity 1,
blue line). Due to the fact that the changes in velocity over distance may be equivalent.
However in terms of history over time, both cosine functions produce a slower deceler-
ation compared with the induced stenosis. This important observation may suggest that
the changes in velocity produced by the needle in soft tissue are larger than the changes
produced in canonical models. This subtle observation can be supported by the non-linear
response of the artery, since it can respond as an hyper-elastic material under load, which
constitutes a material that can experience large deformations and easily take the shape of
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Figure 3.19: Comparison of strain-rate history of fluid streamlines of mechanistic model and
canonical stenosis model. a) Streamlines close 1µm to the wall (B, see Fig 3.18) where aggregation
is expected, over length. b) Streamlines close 1µm to the wall (B, see Fig 3.18) where aggregation
is expected, over time. c) Streamlines of a) but aligned in the deceleration zone. d) Streamlines of
a) but aligned in the deceleration zone.
the blunted micro-needle.
From this investigation it can be concluded that in order to use the canonical model used
commonly in the literature the length of stenosis should be shorter than is commonly used
(twice the vessel diameter) [97, 98, 99, 100, 101, 102, 69, 103], in order to represent the
in-vivo experiment of Section 3.5.1. From this comparison it can be concluded that under
the conditions of low Reynolds number the canonical model using L=200 µm is not the
optimum scenario to study platelet aggregate formation.
3.7 Discussion
The presented investigation has shown that the mechanical properties of a stenosed blood
vessel can have a significant impact on the behaviour of fluid flowing within the vessel.
However, in conducting this study a number of approximations were made to simplify the
numerical computation. This section discusses these approximations and whether they
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should have significant impact on the conclusions that can be drawn.
In our study we have assumed that blood is a homogeneous, Newtonian fluid with the
properties of blood plasma. In fact, blood is a non-homogeneous fluid, in particular about
45-60% of the volume of blood is large red blood cells of around 10 − 30µm diameter.
It has been shown that under flow, these large red cells tend to concentrate at the center
of the blood vessel, with the fluid at the vessel walls being composed mainly of plasma
due to a margination effect ([92, 93, 94, 95, 96]). Conversely platelets tend to concentrate
in this plasma at the vessel walls and it is here that shear stress can cause aggregation.
Hence our approximation that the fluid properties of blood are the same as for plasma are
valid in this region, provided that the stenosis area reduction is significantly larger than
the scale of the red cells themselves.
It is worth noting that when the blood vessel is extremely stenosed (80% - 90% area re-
duction), the channel area will be of similar dimensions to the red cells. At these extreme
degrees of stenosis, red cell collision and deformation is likely to occur leading to non-
Newtonian fluid dynamics, for example the cells may tend to elongate and line up with
streamlines, reducing the viscosity ([104]). However, provided that the stenosis is not
blocked by these events, the flow rate through the stenosis should remain constant and the
strain-rates close to the vessel wall should remain within the same order of magnitude as
the homogeneous plasma case.
An accurate calculation considering the effects of red blood cells including deformation,
collision and interaction with the wall, would certainly be valuable but such a rigorous
model may be beyond what is tractable currently. Significant work in this field can be
found in the literature, ([105]) have considered rigid particles in a simple two dimen-
sional flow while Crowl([96]) has reported a two-dimensional whole blood model where
due to interactions with the deformable red blood cells, platelets can be either pushed
toward the walls into the cell-free layer or move much more erratically in the center of
the vessel. However, to our knowledge numerical models of blood flow in a three dimen-
sional stenosis which include red blood cells have yet to be reported.
In our models we have initiated flow under a uniform inlet condition. In fact, it has been
reported ([97]) that in-vivo blood flow can have a helical component and that this may
increase the viscous stress. Therefore it is possible that the strain-rates that would be
experienced by platelets in-vivo could be higher than predicted by our models. Further
investigation of the impact of this helical flow is warranted, however there is no reported
data on the magnitude of helical flows within small vessels and at very low Reynolds
number.
Along with the approximations made in modelling the fluid dynamics, it is also appro-
priate to discuss the parameters and validity of the in-vivo experiments on which these
models are based. In this study we propose that vessel wall elasticity plays an important
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role in the rheology of steonsis. Control of vessel wall elasticity, in the in vivo experi-
mental setting presented, is a technically challenging problem. The elastic properties of
the vessels may change locally as a function of vessel wall composition, vessel archi-
tecture and the surrounding extravascular tissues. The elasticity of small arteries (capil-
laries and arterioles) is greatly influenced by the amount of surrounding tissue ([104]).
The present computational study is therefore based on carefully chosen (idealized) small
bowel mesenteric arterioles. The choice of arterioles was in part limited by the imaging
setup utilized, such that only vessels with relatively limited amounts of surrounding fat
tissue were assessed.
One possible improvement to the experimental approach would be to directly com-
pare arterioles and adjacent venules that exhibit known differences in vessel wall com-
position and thickness and therefore elasticity’s. However differences in flow rates and
extracellular matrix composition will complicate interpretation of such an experimental
approach. A second possibility would be to compare platelet reactivity and modelled
haemodynamics and elastic properties in apoE-/- mice fed a high fat diet (which have
been demonstrated to exhibit extensive atherosclerotic disease and overt changes in ves-
sel composition), with control (wild type) mice.
Vascular constriction may significantly influence both the extent of the final stenosis and
tissue elasticity. The modelling presented was performed on vessels that did not display
overt constriction following external application of stenosis. The data presented therefore
represents a steady-state snapshot of the vessel at the time of micro-needle compression.
Measurements of the inlet and outlet segments along with the region of stenosis were
made during this relatively quiescent steady-state phase.
3.8 Conclusions
In this chapter it was presented that a stenosis generated by a micro-needle in an arteriole
is able to produce sudden increases in the strain-rate on the micron scale (called shear
micro-gradients). These increases can be on the order of 30 to 60 times the shear rate of
the undeformed arteriole. From the in-vivo experiments of Section 2.3 it was found that
aggregates form in the deceleration zone, suggesting that the initiation of platelet aggre-
gation is likely driven primarily by haemodynamics forces occurring in regions of laminar
flow, where no flow recirculation or vortex formation is evident. This aggregation occurs
when the chemical mechanisms of aggregation (ADP, thrombin and tromboxane) were
blocked further supporting the hypothesis that aggregation is initiated by non-chemical
means.
In general, the modelling presented in this Chapter has provided the order of magni-
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tude of the haemodynamics parameters that may be expected during platelet aggregation
studies in artificially induced stenoses. This will aid understanding of the platelet response
observed during in-vivo experiments.
Computational techniques were applied to an approximate geometry to gain insight
into the order of magnitude of the haemodynamics variables, particularly blood strain-
rates≤ 20000 s−1 were predicted at the stenosis apex that rapidly transitioned to 1862 s−1
within the post-stenosis expansion zone, suggesting that a zone where the strain-rates
are increasing followed by a zone where the strain-rates are decreasing (shear micro-
gradients) may be a requirement for the development of discoid platelet aggregates through
mechanical means. Using an idealized geometry it was possible to identify three princi-
pal components defining a shear micro-gradient or stenosis, the contraction region which
causes acceleration of the platelets, the throat or apex of the stenotic region where peak
strain-rate is experienced and the expansion region that decelerates the platelets.
A second approach of modelling, which took into account the elastic response of an
artery under needle compression and mimicked the in-vivo experiment, enabled detailed
haemodynamics analysis. The method presented to generate the geometry deformed
artery was based on mechanistic simulation and reliably generated geometries which were
very similar to those observed experimentally. Using this model we found that even under
the same stenosis conditions, the arterioles elasticity plays a critical role in determining
both the cross sectional area in the stenosis region and particularly the rate of accelera-
tion/deceleration that the fluid experiences before and after the stenosis. It is hypothesised
that these two variables (cross sectional area and rate of acceleration/deceleration) may
impact in thrombus formation for in-vivo studies. Care must be taken in subsequent stud-
ies to properly quantify the arterioles elasticity as it is possible that the degree of area
reduction is not sufficient to determine the platelet aggregation response. Experimental
in-vivo velocity measurements of the fluid are recommended to validate these predictions.
The geometries obtained using the introduced mechanistic modelling approach was
compared to canonical geometries based on cosines commonly used in research on stenoses.
It was found that the calculation of the strain-rate showed that the more elastic tissue pro-
duced larger changes in velocity and this produced larger strain-rates, contrary to the
cosine shapes where the changes in velocity are smoother. It was noted that the majority
of the investigations using cosine geometries used a stenosis length of twice the vessel di-
ameter. The experiments and simulations presented in this chapter suggest that the length
of the stenosis should be shorter than twice the vessel diameter in order to reproduce the
aggregation response observed the in-vivo experiment. It can be concluded that under
the condition of low Reynolds number the canonical model is not the optimum scenario
to study platelet aggregate formation, since more elastic tissue is able to produce a more
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abrupt and non-trivial changes in velocity which may be important in determining platelet
aggregation response.
It has been shown in this Chapter also that although a certain degree of control of the
geometry and haemodynamics conditions can be achieved through displacement of the
micro-needle or through choice of micro-needle diameter, these parameters often change
more than one variable of the geometry and thus it is difficult to isolate the effects of
different geometric components. It has also been shown that the mechanical properties
of the blood vessels themselves can be quite significant. These will almost certainly vary
from experiment to experiment and thus it is difficult to achieve a strong conclusion about
the role that mechanical stresses play in the initiation of platelet aggregates from these
studies alone. It is therefore necessary to conceive an in-vitro platform to study platelet
aggregation with a more precise control. This is the topic of the subsequent chapters.
The recent adaptation of the mesenteric model of acute thrombosis intra-vital system
to the examination of platelet aggregation responses under conditions of controlled ves-
sel stenosis sets the scene for the current study. The causal relationship between vessel
elastic response to needle compression and the dependent acceleration and deceleration
components of flow through the stenosis may be a significant determinant of the mag-
nitude and rate of the platelet aggregation response, as it has been shown in-vitro on
micro-channels ([4]. Differences in the geometry of the applied stenosis from site to site
or vessel to vessel could affect the thrombus size. Since different fluid forces experienced
as a function of the local geometry affect directly the cell interaction with the wall. This
prediction is borne out by experimental findings within our laboratories which suggest
that the extent of the platelet aggregation is not a simple function of the degree of steno-
sis (unpublished observations). This study demonstrates that although a certain degree of
control of the geometry and haemodynamics conditions can be achieved through displace-
ment of the micro-needle or through choice of micro-needle diameter, these parameters
often change more than one variable of the geometry and thus it is difficult to isolate the
effects of different geometric components. The precise way in which stenosis geometry
impacts on platelet function is currently under further investigation.
Blood vessel wall composition is complex and can differ markedly across the vasculature.
This study highlights the necessity for proper characterisation of the blood vessels under
study from a mechanical properties perspective.
In contrast to the theoretical cosine shapes, where the changes in velocity are relatively
smooth, the simulated geometries experienced higher strain rates.
While the simulation presented has been applied to the specific case of micro-needle
stenosis in the small bowel mesenteric thrombosis model it has direct application to and
implications for the analysis of platelet function in a number of so called “high shear“
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dependent thrombosis models ([106, 107, 51]), where a silk suture is tied around an artery
to cause a concentric stenosis.
The simulation presented demonstrates that under generalized externally applied steno-
sis, the arteriolar non-linear elasticity plays a critical role in determining both the cross
sectional area in the stenosis region and significantly, the rate of acceleration/deceleration
that the blood experiences before and after the stenosis. Future work will involve more
advanced computational models considering non-homogeneous and non-Newtonian flu-
ids under realistic in-vivo stenosis geometries. In conclusion, the simulation presented
should be a useful tool in the investigation of the impact of the mechanical blood flow
environment on platelet function and thrombosis.
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In-vitro disturbance: spherical
micro-protrusions in capillary channels
4.1 Contributions
I performed the fluid dynamic simulations to characterizse the second set of experiments
described in Chapter 2. The images from these analyses were published in [1]. I proposed
to analyse not only the strain-rate distribution at the surface of the bead, but also the fluid
streamlines. I proposed comparing these simulations with an analytical solution. The nu-
merical simulations with minor modifications were published in:
W. S. Nesbitt, E. Westein, F. J. Tovar-Lopez, E. Tolouei, A. Mitchell, J. Fu, J. Carberry,
A. Fouras, and S. P. Jackson, “A shear gradient-dependent platelet aggregation mechanism
drives thrombus formation.,” Nat Med, vol. 15, pp. 665–673, Jun 2009. [1]
4.2 Introduction
Chapter 3 presented an analysis of an in-vivo experiment where a micro-needle was used
to create an artificial stenosis which could initiate platelet aggregation under conditions
where the common chemical activating mechanism of platelet aggregation were blocked.
The investigation in Chapter 3 attempted to model the haemodynamics conditions that
would be experienced by the platelets flowing through this stenosis using a subjective
qualitative model and a mechanistically simulated geometry. These investigations demon-
strated qualitatively that a micro-scale stenosis produces a sudden increase and subsequent
decrease in the flow strain-rates that closely correlate with the regions where platelet
58
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aggregation was found to occur experimentally. Significantly, platelet aggregation was
found to occur in the deceleration zone of the stenosis rather than in the high shear zone
as has been reported in earlier studies [31, 42, 43]. Using the fluid mechanical insight
obtained from the investigation in Chapter 3 in combination with biological models of
platelet aggregation it was concluded that the aggregation was most likely due to non-
chemical factors. It was thus hypothesised that fluid mechanics play a critical role in the
initiation and development of platelet aggregates and thus it was deemed of great interest
to study the mechanical conditions and their impact on platelet response. Using the ex-
perimental in-vivo approach described in Chapter 3 it was found that although the peak
strain-rate could be accurately controlled using the degree of stenosis, the total strain-
rate history including acceleration and deceleration components was highly variable and
dependent on parameters such artery wall elasticity which is difficult to control in a sys-
tematic manner. Given that platelet aggregation was found exclusively in the deceleration
zone of the in-vivo stenosis, it was hypothesised that not just high strain-rates but the
total strain-rate history is a significant factor in determining platelet aggregation which
may explain why aggregation is only observed under certain specific in-vivo experimen-
tal conditions.
Due to the fact that in-vivo parameters are highly complex and difficult to control, with
variations existing in geometry, elasticity, platelet function and chemical environment, it
was very difficult to conceive of an in-vivo experiment that could prove the importance
of total strain-rate history in the initiation of aggregation. It was thus decided to pursue
a simplified in-vitro model that could isolate the parameters of interest while eliminat-
ing many of the variables encountered in the in-vivo experiment. Historically in-vitro
experimental approaches examining blood flow have been conducted using parallel flow
chambers, Couett cells [37, 38, 39] or rectangular capillaries [40, 41, 11, 6, 7]. Rect-
angular capillaries in particular have become popular in recent years due to their relative
ease of use and easy application to transmitted light micro-imaging techniques. Since the
cross sectional area of a rectangular capillary is constant along the direction of flow, the
fluid at any point in the cross-section experiences a constant velocity and constant shear-
rate as during steady. The rectangular capillary is thus an excellent tool for studying the
role of haemodynamics at a constant shear-rate on blood cells. Capillaries can also be
easily coated with specific proteins to study the function and interaction of platelets un-
der a wide range of constant shear-rate. A number of experiments were conducted to
study platelet-protein matrix interactions under flow at the Australian Centre for Blood
Diseases [33, 44]. During some of these experiments, it was observed that occasionally
single platelets adhered to the surface of the capillary and this by itself was apparently suf-
ficient factor to trigger platelet adhesion and subsequent accrual of new platelets from the
flow (unpublished observations). However, due to the stochastic nature of platelet-surface
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interactions under flow it was difficult to predict where an platelet aggregation would
occur. Based on these limitations a method was developed to locally modify the capil-
laries to initiate single platelet adhesion at a pre-defined location, modifying the surface
of the capillary to create a flow disturbance, similar to Chapter 3, but using a canonical
disturbance that could be easily controlled and analysed.
This chapter presents the application and characterisation of a micro-bead disturbance
assay to examine platelet aggregation under defined blood flow conditions and a series
of investigations of the fluid dynamics produced by micro-spheres adhered to the wall
of a rectangular microfluidic capillary. The Chapter is structured as follows. Section 4.3
presents a review of the theory of fluid mechanics and a solutions for flow around a sphere.
Section 4.4 presents a more complete solution for the viscous flow around a sphere fixed
on the wall of a rectangular capillary using a numerical approach. It is presented an
estimate of the flow disturbance produced by a sphere in a rectangular capillary. Distinct
flow parameters are extracted from an estimate of the flow disturbance produced by a
sphere in a rectangular capillary, which are correlated to platelet aggregation behaviour.
Section 4.5 presents the relative error of using both methods for specific variables of
interest of fluid mechanics. Section 4.6 then presents a summary and conclusions from
this chapter.
4.3 Flow around a sphere: analytic calculation
In this section, an idealized model of the fluid flow around a bead attached to the wall
of a rectangular stenosis is presented. A closed-form analytic solution for the strain-rates
caused by this bead is developed. Section 4.3.1 presents an overview of the problem def-
inition and the important fluid dynamic variables that are sought. Section 4.3.2 presents
the analytic simulation approach used to obtain an approximate model for the strain-rates
and also the approximations and limitations associated with this approach. Section 4.3.3
presents the results of this analysis and discusses the validity of these approximate re-
sults in comparison with the in-vitro experiments of Section 2.4. Section 4.3.4 discuss
some limitations of the analytic approach. Section 4.3.5 then presents a summary and
conclusion of the analytic fluid dynamic calculation.
4.3.1 Problem description
It is possible to calculate the haemodynamics of the flow around a spherical object on the
wall of a rectangular capillary if a number of important parameters of the flow are known.
These include the shear-rate at the walls of the capillary of the unperturbed flow, the
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rectangular channel geometry and the sphere diameter. In the experiments of Section 2.4,
a constant blood flow rate was maintained to produce a shear-rate of 10,000s−1 at the
bottom and top wall of a rectangular channel. The channel dimensions were 2mm ×
0.2mm. Fixed spheres with similar size diameters to platelets (2µm) were used (2, 5, 9
and 15µm). A diagram of the geometry with the important parameters labeled is presented
in Figure 4.1.
1 x 0.1 µmlayer of protein 
   2000 µm
2µm 5µm 9µm 15µm
8 cm
blood flow
2
0
0
µ
m
y
x z
y
z x
Figure 4.1: Spherical obstacle in a constant flow rate field.
In order to analyse the impact of the bead on the initiation of platelet aggregation it
is necessary to know a number of important haemodynamics parameters. For example,
the effect produced by the sphere on the strain-rate at the wall near the bead, the strain-
rate distribution on the surface of the sphere itself, the strain-rate distribution within the
volume of the channel in the neighborhood of the sphere, and, similar to the investigation
of Section 3.5.7 the strain-rate history for particles travelling along streamlines close to
the micro-sphere surface, and finally whether recirculation exists.
4.3.2 Analytical method of viscous flow around a sphere
In order to solve the problem defined in Section 4.3.1, the analytical solution of Stokes
for viscous flow around a sphere can be is presented, which describes the motion of fluid
substances. The Navier-Stokes equation for an incompressible Newtonian fluid with uni-
form viscosity was introduced in Chapter 3 as Equation 3.2. For the convenience of the
reader it is repeated in its full form as
ρ[
∂~u
∂t
+ ~u · ∇~u] = −~∇P + µ∇2~u+ ~f (4.1)
Where ρ is the density of the fluid, ~u is the velocity vector, P is the pressure, µ is the
viscosity and f denotes any external body forces. This equation arises from applying the
::::
::::
::::
: O
nli
ne
Pu
bli
c V
ers
ion
. F
ran
cis
co
J.
To
va
r-L
op
ez
. R
M
IT
. A
pri
l 2
01
1 :
::::
::::
::::
CHAPTER 4. 62
blood flow θ
R
r
Figure 4.2: Flow around a sphere fixed on the space.
Newton’s second law to fluid motion, together with the assumption that the fluid stress
is the sum of a diffusing viscous term (proportional to the gradient of velocity), plus a
pressure term. On the other hand to get more insight about the regime of the flow whether
is laminar or turbulent the Reynolds number can be used and is defined as:
Re =
ρUl
µ
(4.2)
where l is the characteristic length, which in this case is the diameter of the micro-bead
and, U the mean fluid velocity. For micro-flows, usually the characteristic length is short
and the velocities low. This results in a low Reynolds number which means that flow is
laminar. For the present case, the Reynolds number is between 0.01 and 0.64 depending
on the bead size. In order to present an analytical approach to solve the Equation 4.1, it
is assumed that effects of the inertia forces are minimal (i.e. the inertial term ~u · ∇~u is
disregarded, although for the present case the magnitude of the inertia forces is roughly
similar to the viscous forces). Also since the flow is steady the time derivative is also zero,
and no external body forces exist, the Navier-Stokes Equation 4.1 can be reduced to:
∇p = µ∇2~u (4.3)
One method of solution for this equation is by stream functions and assuming that the
sphere is fixed in the space. The geometry of the simplified problem with the assumption
is depicted in Figure 4.2. For convenience the origin is located in the center of the bead
and r is the radial coordinate, θ is the angle andR is the radius of the sphere. Therefore by
applying a stream function, using spherical coordinates and applying the proper boundary
conditions, the velocity field can be expressed as Equations 4.4 and 4.5:
ur = Ucosθ(1− 3R
2r
+
R3
2r3
) (4.4)
uθ = Usinθ(1− 3R
4r
+
R3
4r3
) (4.5)
::::
::::
::::
: O
nli
ne
Pu
bli
c V
ers
ion
. F
ran
cis
co
J.
To
va
r-L
op
ez
. R
M
IT
. A
pri
l 2
01
1 :
::::
::::
::::
CHAPTER 4. 63
A detailed derivation of the solution that leads to Equations 4.4 and 4.5 can be found
in [83]. This result was obtained by Stokes in 1851 considering a flow where the vis-
cous forces are much bigger than the inertial ones (Re<<1), therefore the accelerations
of the fluid around the sphere can be ignored, resulting in an equation that can be solved
analytically. This analytical solution describes the flow around a sphere, considering that
the sphere is fixed in the space, therefore the solution is axisymmetric along the direction
of the flow. Equations 4.4 and 4.5 describe the theoretical distribution of velocity as a
function of distance r from the center of the sphere and the angle θ measured around the
sphere from 0◦ at the front point to 180◦ at the rear point. It can be noticed from Equa-
tions 4.4 and 4.5 that as the radial distance increases (r →∞) the velocity approaches its
free stream magnitude and direction as expected. To calculate the strain-rates, the veloc-
ity gradient can be found from Equations 4.5, since the component of drag force per unit
area in the direction of the uniform stream is:
F = −pcosθ + τrrcosθ − τrθsinθ (4.6)
The components of viscous stress are:
τrr = 2µUcosθ[
3a
2r2
− 3a
3
2r4
] (4.7)
τrθ = µ[r
∂
∂r
(
uθ
r
+
1
r
∂ur
∂θ
)] = −3µUa
3
2r4
sinθ (4.8)
so that Equation 4.6 becomes
0 +
3µU
2a
cos2θ +
3µU
2a
sin2θ =
3µU
2R
(4.9)
From Equation 4.9 it can be observed that the maximum strain-rate around the sphere
is located at the apex of the sphere when θ = 90◦.
4.3.3 Fluid velocity profile in a rectangular capillary
To calculate the strain-rates using Equation 4.9, the undisturbed (upstream) velocity at
the bead must be quantified. This can be approximated as the velocity that would be
expected at the location of the bead in close proximity to the rectangular channel wall.
To calculate this velocity it will be necessary to determine the fluid velocity profile in
a rectangular capillary. The velocity profile of a rectangular capillary can be obtained
either using computational fluid dynamics or through analytical equations [108]. For
the current investigation, computational fluid dynamics using the geometry depicted in
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Figure 4.1 (but without the bead) and the numerical technique described in Section 3.4.2
was used. Figure 4.3 presents the velocity profile that would be expected parallel and
equidistant from the two vertical walls of the channel at a height ranging from the bottom
of the channel to the top. This velocity profile is approximately parabolic as is expected
from analytic theory [108]. The inset of Figure 4.3 presents a magnified view of this
velocity distribution ranging from the capillary floor to 15µm above the floor. This is
the region where the beads will be located. The values of the tangential velocity and the
correspondent shear rate are presented in Table 4.1. Another variable of interest that may
be calculated in close form and also extracted from numerical simulation is the drag force
experienced by the sphere. This drag force can be calculated by using the Newton’s law
of viscosity:
τ = µ
dθ
dr
(4.10)
where τ is the stress. Since stress is force over area, by combining Equation 4.9 and
Equation 4.10 the drag force equation can be obtained as:
Fx = 6piµUa Fy = Fz = 0 (4.11)
whereD is the drag force inNewtons, U the mean velocity and a the radius of the sphere.
By applying the use Fourier-Bessel transforms, an exact solution of the Navier-Stokes
equations for a sphere touching a plane can be derived [109] and analytical equations
for the drag and torque can be obtained. It is deduced for a fixed sphere in a plane, the
drag force equation follows the same form but with an additional factor f = 1.7009, as
follows:
Fx = 6piµUaf Fy = Fz = 0 (4.12)
and the torque that the sphere is experiencing can be expressed in Cartesian components
as
(0, 0,−8piµUa2g) (4.13)
where g=0.94399. Using these equations the drag force and torque that the micro-spheres
will experience can be calculated and the results are also presented in Table 4.1.
Comparing the mechanical parameters presented in Table 4.1, the first interesting re-
sult to observe is that although the flow velocity experienced by the sphere increases in
approximate proportion to the sphere diameter, the maximum shear rate predicted at the
apex of the sphere falls in the same range, independent of the diameter. This can be ex-
plained as follows: Equation 4.9 predicts that the shear-rate will decrease inversely with
radius, but the velocity U is increasing approximately in proportion with r, due to ve-
locity profile of the rectangular geometry (as shown in Figure 4.3). Therefore a bigger
bead experiences a higher velocity U which cancels the increase in shear due to a larger
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Figure 4.3: Velocity profile for a rectangular capillary of 2mm × 200µm along the 200µm di-
mension, with a zoom in in the region 0-15µm where the micro-beads are located to obtain the
tangential velocity values.
Table 4.1: Fluidic parameters calculated for spherical beads of various diameters. Flow velocity
derived from computational fluid dynamics in a rectangular capillary as depicted in Figure 4.3,
strain-rates as derived from Equation 4.9, Drag Force calculated using Equation 4.11 and Equa-
tion 4.12 and torque calculated using Equation 4.13.
Sphere φ Vel. Shear-rate Drag Force Stokes Drag Force [109] Torque
[µm] [mm/s] [s−1] [nN ] [nN ] [nNµm]
2 0.2 30000 0.219 0.373 0.276
5 0.5 29400 1.344 2.28 4.23
9 0.87 29333 4.34 7.39 24.60
15 0.14 28000 11.52 19.58 108.74
bead diameter. Recall that the shear-rate is the rate of change of velocity over the radial
distance, then a larger velocity magnitude is compensated by a larger curvature on the
sphere size. It can also be noticed that the order of magnitude of the drag and torque is
in the order of nN and nNµm, respectively, and that they are proportional to the sphere
diameter.
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4.3.4 Limitations of the analytical approach
This analysis assumed that the sphere was fixed in place by some abstract means and
was not physically connected to the capillary wall by any means that would disturb the
flow. The consideration utilized by Stokes treating the sphere as fixed in space is just an
artifact which is useful to understand the viscous flow around a spherical object. A real
implementation may exhibit different properties. In the experiment of Section 2.4, the
sphere was fixed in place by a small layer of protein (approximated as a disc of dimensions
of 0.1µm × 1µm as shown in Figure 4.1). It has been observed experimentally [94, 95]
and corroborated by some recent numerical models [96] that platelets travel close to the
wall when flowing in blood, and thus they are likely to experience the perturbation caused
by the means of fixing the bead to the wall. The hypothesis of this chapter was that subtle
changes in the total shear stress history experienced by the platelet would be significant
in determining the initiation of platelet adhesion and aggregation and thus it is important
to have a precise model of the shear stress history that would be experienced by a platelet
adhering to the surface of the bead. It is thus necessary to accurately model the shear
stress history along streamlines of flow travelling close to the wall of the capillary, and
this is the zone where the Stokes solution for a sphere (far from a plane) lacks validity.
An alternate solution has been proposed by O’Neill [109]. An attempt was not made
to implement this model as it was deemed difficult to carry out numerically in order to
have a 3D visualization, compared with a finite volume technique, where the author is
more familiar. However, O’Neill’s [109] solution has been useful to compare specific
values of forces and torqu s to validate the numerical model. Furthermore, according to
the biological experiments platelets seem to adhere to the back of the sphere and adhere
to the bottom wall. It would be instructive to know the shear rates associated to these
particular zones.
4.3.5 Conclusions of the analytic model of flow around a bead
Although the analytical model of this section provides the interesting insight that the peak
shear stress experienced by a platelet interacting with a bead should be independent of the
bead diameter, this model is not sufficient to accurately determine the total shear stress
history experienced by a platelet flowing around a bead that is physically attached to the
wall of a capillary. It is thus necessary to perform more rigorous computational fluid
dynamic analysis of the fluid flow in this geometry.
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4.4 Flow around a sphere on the wall of a rectangular
capillary: numerical calculation
Section 4.3.2 used an analytical approach to estimate the flow field around a sphere. This
provided order of magnitude estimates of the mechanical properties of the flow and the
interesting insight that maximum strain-rate should be independent of sphere diameter.
It was, however concluded that more rigorous computational fluid dynamics would be
required in order to precisely determine the strain-rate history that could be expected
along the streamlines close the the capillary wall and the surface of the bead in order to
draw any strong conclusions about the role of strain-rate history has in the initiation of
platelet aggregates observed in Section 2.4.
Advancements in computational methods allow access to a more complete description
of the haemodynamics and visualization in three dimensions of the phenomena which can
provide greater insight for both biologists and scientists not necessarily familiar with the
theoretical constructs and approximations used to obtain analytic equations such as those
presented in Section 4.3.2. Therefore the goal of this section is to achieve accurate es-
timates of the strain-rate history that would be experienced by platelets aggregating on
spherical beads on the walls of rectangular channels, and compare these to the experi-
mental observations of Section 2.4 and the analytic predictions of Section 4.3.2.
4.4.1 Discretisation and Boundary Conditions
The geometry of the beads and capillary was modeled in Ansys by creating a script where
the variables were parameterized, the result was exported using an IGES file and imported
to GAMBIT (all cases) and ICEM (bead 15µm). To create the discretization in GAMBIT,
the mesh consisted of two zones, an unstructured region close to the bead and a structured
mesh everywhere else.
A symmetrical condition was applied at the center plane of the beads to reduce compu-
tational load. The number of cells in the structured mesh generated was directly dependent
on bead size ranging from 754,446 (2 µm beads) to 954,516 (15 µm beads).
For the geometry in ICEM a structured mesh composed of hexaedrals using the block
topology was created for comparison purposes. In order to calculate the velocity for the
inlet boundary condition, it is not correct to apply the Equation [3.14] which is useful
for cylinders, as the present capillary geometry is rectangular. For geometries where the
width is much smaller that the height (at least 5 times) the shear-rate γ˙ can be written
γ˙ =
6Q
wh2
(4.14)
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where Q is the flow rate (defined as Q = u w h) in [ml
sec
]. The width w corresponds to
2000µm and the height h to 200µm, in cm. Using Equation 4.14 in order to achieve a
shear-rate of γ˙=10,000[s−1] the flow rate must be Q = 8[ ml
min
]. Therefore it is possible to
calculate the velocity that should be imposed at the inlet boundary condition to produce
a shear-rate of 10,000[s−1]. The boundary condition at the walls and at the bead surface
was set as zero velocity to enforce the no slip condition. The boundary condition at the
outlet surface was a relative pressure of zero (Pa).
4.4.2 Computational Fluid Dynamic Solution
Once the discretized volume was built, a finite volume scheme using the commercial soft-
ware (FLUENT 6.0, Fluent USA, Lebanon, NH) was used in order to solve the Navier-
Stokes equations numerically. The same fluid medium used in Section 3.5.4 was used.
Therefore a Newtonian fluid was considered with a density of (ρ = 998.2 kg
m3
) and a vis-
cosity of (µ = 0.00348Pas), since blood can be approximated as a Newtonian fluid if the
strain-rates are high[75]. The pressure discretizati n scheme was set as standard and the
second order upwind momentum option was enabled.
4.4.3 Strain-rate distribution on sphere and plane
Figure 4.4a) shows the strain-rate calculated at the surface of a spherical bead of diameter
15µm and also the strain-rate at the surface of the channel wall. The streamlines located
in a plane 7.5µm above the surface of the channel wall are also depicted (at the center of
the sphere). The strain-rate is highest at the top of the sphere. The strain-rate ranges from
zero at the base of the bead (where the bead is stuck to the channel), to approximately
30000s−1 on the sides of the bead to approximately 60000s−1 at the top of the bead.
The numerically calculated strain-rate of 30000s−1 observed on the sides of the bead
is in good agreement with the analytical predictions presented in Table 4.1. Figure 4.4b)
presents a longitudinal cross-section of the bead in flow. Here the streamlines are shown
in the plane parallel to the direction of flow and bisecting the bead. Figure 4.4b) illustrates
the departure of the computational model from the analytic model of Section 4.3.2. The
streamlines divert preferentially over the bead and the peak strain-rate is found on the top
of the bead. This peak strain-rate of 60000s−1 is approximately twice that predicted in
Table 4.1. This can be explained by the fact that more of the fluid must flow over the top
of the bead as the bottom is obstructed by the capillary wall. Figure 4.4b) also shows that
the bead produces a zone of low strain-rates on the capillary wall. This can be seen as
a dark blue shadow on the upstream face, the downstream face and the underside of the
bead and is evident on the capillary wall extending approximately a bead diameter both
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before and after the bead.
The streamlines in the plane 7.5µm above the surface of the channel wall flow around
the bead in a very symmetric fashion indicating laminar flow with no evidence of flow
separation. The symmetric form of these streamlines compares well to the analytic pre-
dictions of Section 4.3.2. The streamlines are useful to observe to intrepret flow behavior
past a stationary sphere. At this low Reynolds number the streamlines are symmetrical be-
fore and after passing the sphere. It is interesting to note that the accumulation of platelets
downstream of the sphere at low Reynolds numbers is present even although the stream-
lines are symmetrical. This suggest that a non-physical (biological) mechanism may lead
the aggregation.
Figure 4.4: Perspective view of the bead of 15µm and streamlines. a) It can be observed that the
maximum stress is occurring in the bead surface and following the streamlines, the bead provides
a zone of low shear (blue shadow) after the maximum shear. This zone of low shear is located
in the bead itself, downstream the flow, but also at the bottom surface of the capillary channel.
b) Representation of the streamlines from the bottom wall to 15µm. It can be observed that the
streamlines are adapted to the geometry of the spherical obstacle
Figure 4.5 presents the numerically calculated strain-rate distribution for a 2µm and
15µm bead. The 2µm bead produces a very similar strain-rate distribution to the 15µm
bead. This is in good agreement with the analytic predictions presented in Table 4.1. It
can be observed that the low strain-rate region presents the same distribution proportional
to the bead size. It is hypothesised that if platelets experienced the peak strain-rate on the
top face of the bead and then drop into this low strain-rate shadow, they will experience
the ideal conditions for aggregation where filamentous membrane tethers (cylinders of
lipid bilayer) are pulled from the surface of discoid platelets by high strain-rates [44, 1],
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but a low strain-rate zone allows them to interact with the bead and channel surface and
with each other without being forcibly separated. This bio-physical mechanism may be
enhanced by a localised shear-enhanced diffusion of platelets which is a phenomena that
allows them to migrate across streamlines to regions of low shear [110].
φ 2µm φ 15µm
Strain-Rate [s ]
-1
Figure 4.5: Perspective view of the strain-rate distribution for a 2µm and 15µm micro-spheres.
4.4.4 Strain-rate history along streamlines
In Section 4.4.3 computational fluid dynamics simulations established the strain-rate dis-
tribution of the fluid flowing around a spherical bead on the wall of a rectangular profile.
It was found that large and small beads should produce approximately the same peak
strain-rate. The spherical beads would produce high strain-rates regions at their apex and
to a lesser degree on their sides. It was also shown that regions of reduced strain-rates
would be created on its upstream and downstream faces.
The next step in this investigation was to compare the history of selected streamlines.
Figure 4.6 presents a comparison of the strain-rate experienced by a particle traveling
along a streamline that passes at 1µm from the top surface of the micro-bead as a function
of distance travelled. The strain-rates for beads of diameter 2µm and 15µm are shown.
Figure 4.6 shows that the flow first decelerates as it approaches the bead which is
related to the fluid being diverted by the bead, this results in a flow stagnation region. The
flow then changes of direction, accelerates and increases on the strain-rates until a peak at
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the apex of the bead. The flow then decelerates on the downstream side of the bead again
reaching a stagnation point shortly after the peak strain-rate is experienced. This occurs
on a region of 40µm.
For the 15µm bead the particle at the capillary wall experiences a strain-rate of ap-
proximately 9000s−1 before encountering the bead. The strain-rate then drops below
2800s−1 before rising abruptly to approximately 29000s−1 and then dropping again to
approximately 2800s−1 within 10µm of experiencing the peak strain-rate. The streamline
then rejoins the flow at 9000s−1 within about 10µm of the center of the bead. For the
2µm bead, the changes are far more rapid with distance.
The minimum strain-rates experienced in the stagnation points before and after the
bead are at approximately the same values as the 15µm bead. The peak strain-rates are
somewhat lower, which is at first unexpected, considering the predictions of Table 4.1
and Figure 4.4. However through examination of Figure 4.4, the reduced peak strain-
rates predicted for the smaller bead are probably limited by the choice of streamlines
within 1µm of the surface. For the smaller bead this is an entire bead diameter away from
the flow disturbance and the local increase in strain-rates will have reduced significantly.
For the larger bead, the 1µm distance from the surface is far less significant. This factor
may be important when drawing conclusions about the impact on strain-rates history on
platelet aggregation for different sized beads.
Reviewing the in-vitro experiments depicted in Figure 2.4, it is evident that both large
and small beads are capable of inducing a dynamic discoid platelet aggregation response
at the downstream face of the bead. The location and size of the aggregate corresponds
well with the stagnation region shadow on the downstream side of the bead where the
strain-rates are lower than for the surrounding regions on the capillary wall. This is less
obvious for the smaller beads which may be explained as the aggregate itself is larger than
the bead and thus will dominate the local fluid dynamics.
Figure 4.7 presents the strain-rates history of particles flowing along the same stream-
line trajectories as in Figure 4.6, but with strain-rates experienced plotted as a function of
time. The differences between the time scales over which the strain-rates are experienced
for the 15µm and 2µm beads is now far less pronounced. This can be explained as the
acceleration for a particle 1µm from the surface of the 15µm bead is far greater than for a
particle the same distance from a 2µm bead. Thus the particle traverses the larger distance
across the surface of the larger bead more quickly.
It is also worth noting that the particles remain in the low strain-rates region for a
period on the order of milliseconds. Particles interacting with the 15µm bead remain
in the stagnation zone for more than 3 milliseconds while particles interaction with the
2µm bead are exposed to low strain-rates for approximately 0.5 milliseconds. The time
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spent in the low strain-rates shadow of the bead is clearly dependent on bead size but the
magnitude of the reduced strain-rates in the stagnation zones is independent of bead size.
It should be noted that once platelets aggregate at the back of the bead they will be-
come important factors that will alter the flow, since they are adhering to the sphere wal-
land hence changing the sphere geometry. Ongoing platelet recruitment drives the prop-
agation of the thrombus in the downstream of the bead, which may in turn amplify the
strain-rate distribution and promote further platelet aggregation. This effect has been ig-
nored in the current analysis, however the nonlinear fluid dynamics of platelet aggregation
would provide a very rich avenue for future investigation.
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Figure 4.6: Fluid strain-rates following a streamline over length around a 15µm and 2µm micro-
sphere.
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Figure 4.7: Fluid strain-rates following a streamline over time around a 15µm and 2µm micro-
sphere.
4.4.5 Recirculation test
Despite the fact that both the analytic theory of Section 4.3 and the computational fluid dy-
namic results of Section 4.4 predicted no flow separation or recirculation for the Reynolds
number of the experiments and simulations, the findings of the biological experiments in
Section 2.4 showed platelet aggregation at the downstream face of the bead, where flow
recirculation could be observed for much larger Reynolds numbers. Therefore it was
deemed important to investigate the conditions under which flow separation could be
observed at the back face of the bead and ensure that both the experimental and compu-
tational conditions were not in this regime so that recirculation could be ruled out as a
cause of the observed aggregation [20]. It is worth mentioning that the analytical Stokes
flow solution can not give rise to flow separation. Therefore the recirculation test was
performed just on the base of the bead attached to the wall using computational fluid
dynamics.
In order to test the mesh capabilities of flow recirculation, different flow rates were
imposed. Figure 4.8a) shows the velocity vectors at the downstream face of the bead for
the Reynolds number used in the experiment (Re=0.86), Figure 4.8b) and Figure 4.8c)
shows the same velocity vectors using flow rates increased by a factor of 10 (Re = 8.6),
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and 100 (Re = 86) respectively. It can be observed that flow recirculation start to appear
at Re= 86 which is consistent with the theory [111]. This test corroborates that at least
for a homogeneous fluid recirculation would only be expected at the downstream face of
the bead for Reynolds approximately 100 times that used. It can be concluded that the
platelet aggregates at the downstream faces of the beads are due to some other biophysical
phenomena other than flow separation.
a)  Re= 0.86 b) Re= 8.6 c) Re= 86
Figure 4.8: Recirculation test for a 9µm micro-sphere..
4.4.6 Comments on blood cell concentration profile
It has been reported that under physiological conditions, in the presence of red blood cells,
platelets concentrate in a reg on close to capillary walls, for examples of these it is rec-
ommended to read the following articles: [92, 93, 94, 95, 96]. This non-homogeneity of
the fluid composition suggests experiments were not consistent in comparing the effects
of single mechanical variables on platelet aggregation. By changing the bead diame-
ter, the region where the maximum strain-rate is generated is potentially exposed to a
different platelet concentration according to the bead diameter. Hence a larger bead is
potentially exposed to less platelet concentration than a smaller bead. This effect of non-
homogeneous platelet concentration across the channel cross-section has been neglected
for the current investigation, but will be the subject of future investigations.
4.5 Flow around a sphere: Comparison of the analytical
and numerical solution
A parallel step during the numerical solution was to compare the values calculated with
the analytical result, for validation purposes. The values of drag force and torque are not
relevant to the platelet aggregation phenomena for the present study, but are quantities
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of common use in fluid mechanics calculations and useful to compare the methods used
in previous sections. Therefore in this Section the values of drag force and torque ob-
tained from CFD are presented and will be compared with the values calculated from the
analytical solution presented in Table 4.1.
4.5.1 Drag force and Torque value comparison
Table 4.2 presents a summary of the numerical results. The strain-rates were taken from a
plane at the middle of the sphere parallel to the surface of the capillary, where the values
were obtained from the analytical solution. Due to the condition of axisymetry, these
values should be closer to the numerical values to the numerical values.
Table 4.2: Strain-rates, drag force and torque obtained from the numerical solution for spherical
beads of various diameters..
Sphere diameter CFD Strain-rates Drag Force CFD Torque
[µm] [s−1] [nN ] [nNµm]
2 27500 0.3979 0.271
5 27000 2.402 4.08
9 26800 7.658 23.24
15 26000 20.73 102.6
It can be observed that for the location where the strain-rates were calculated (a plane
at the middle of the sphere parallel to the surface of the capillary) falls within the same
range of the analytical solution, however as it was presented in Section 4.4.3 the maximum
strain-rate is located at the top of the bead and has a different magnitude.
4.5.2 Error Drag force and Torque
Table 4.3 presents the calculated error for the analytical solution presented in Table 4.1
and the CFD results presented in Table 4.2 for the drag force and torque calculation. It can
be observed that in terms of the drag force, the Stokes force calculated with Equation 4.11
shows a considerable difference with the CFD. Case contrary is the value obtained using
O’Neill’s [109] solution (Equation 4.12), where the values obtained using CFD are closer.
From this point the next step was to compare the torque obtained using O’Neill’s [109]
solution (Equation 4.13) and CFD, it is shown in Table 4.1 that the values are in good
agreement.
As a summary it can be concluded from Table 4.1 that the numerical solution applied is in
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Table 4.3: Comparison of the analytical solution and CFD for drag force and torque in terms of
error.
Sphere diameter Drag Force Stokes Drag Force O’Neill Torque
[µm]
2 81.35% 6.68% 1.77%
5 78.73% 5.13% 3.36%
9 76.29% 3.73% 5.54%
15 79.92% 5.84% 5.65%
good agreement with the analytical solution even without a grid independent check, that
would be of benefit to study the error calculated.
4.6 Conclusion
This chapter focussed on haemodynamics characterisation of an in-vitro experiment where
blood flowed through a simple rectangular capillary with spherical micro-beads attached
to the walls. Similar to the in-vivo experiments of Chapter 2, the chemical initiators of
aggregation were suppressed, yet aggregation was still observed. The simplicity of this
experimental platform enabled the application of fundamental fluid mechanics to under-
stand the fluidic behavior and gain insight into the more important environmental condi-
tions that would be experienced by platelets flowing across the surface of the beads. It
was shown that the disturbance that the micro-beads produce in the flow close to the sur-
face of the bead is a sudden increase and decrease in the strain-rates. It was demonstrated
using theory and simulations that the peak strain-rates produced at the apex of the bead
is similar in magnitude regardless of the diameter of the bead, however aggregation was
not observed uniformly for all bead diameters. This clearly suggests that it is not only
high strain-rate that are required to initiate platelet aggregation. Importantly analysis of
the fluid dynamics indicated that the larger beads which exhibited more consistent ag-
gregation produced a prolonged spatial and temporal stagnation zone of low strain-rates
downstream of the bead. It is in this region where platelet adhesion and aggregation is
observed. It was also shown that the observed aggregation cannot be attributed to flow
separation and recirculation as flow rates would need to be nearly 100 times those used in
both experiment and theory before recirculation would be expected.
The simplicity of this in-vitro model is also a weakness. Only one variable can be ad-
justed which is the bead diameter. While changing bead diameter does not fundamentally
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change the peak shear observed at the surface of the bead, the streamlines 1µm from the
surface of the bead do experience significant differences in peak shear and thus it is dif-
ficult to examine the effect of acceleration and deceleration in isolation from peak shear
for real platelets with dimensions on the order of 1µm.
By performing analytical and numerical calculations it was demonstrated that al-
though changing bead diameter does not fundamentally change the peak strain-rate ob-
served at the top surface of the bead, by comparing different beads, the location of the
peak strain-rate from the bottom surface of the capillary, for different beads is different.
Another difference is that the peak strain-rate produced by a larger bead is situated in a
higher velocity zone compared with a smaller bead. Therefore platelets may experience
the peak strain-rate but different drag forces depending on the bead size.
On the other hand using the spherical geometry of the bead makes it difficult to control
the streamlines that platelets 1µm may follow in close proximity to the bead meaning
significant differences in peak strain-rates may be experienced for equivalent trajectories
from the capillary perspective. Thus it is difficult to examine the effect of acceleration
and deceleration in isolation from peak strain-rates for platelets with dimensions on the
order of 1µm.
Finally it has been reported that in the presence of red blood cells, platelets concen-
trate in a region close to capillary walls, this non-homogeneity of the fluid composition
produce that the experiment is not consistent in comparing the effects of single mechani-
cal variables on platelet aggregation. By just changing the diameter, the region where the
maximum strain-rate is generated is potentially exposed to a different platelet concentra-
tion according to the bead diameter. A larger bead is potentially exposed to less platelet
concentration than a smaller bead.
Based on the findings presented in this chapter it was identified that a more defined
and controllable approach was required to examine the haemodynamics parameters un-
derlying discoid platelet aggregation processes. More precise control of the magnitude,
duration, localization of the peak strain-rate and also the rate and duration of the acceler-
ation and deceleration before and after this peak strain-rate is required to accurately map
the effects of local haemodynamics to platelet aggregation. Such precise control would
enable strong conclusions to be drawn about the relative roles of the peak strain-rate and
the local haemodynamics prior to and after this peak strain-rate in initiating and promoting
aggregation. Thus a more sophisticated micro-fluidic platform is proposed in Chapter 5.
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In-vitro disturbance:
micro-contractions in capillary channels
5.1 Contributions on this chapter
I designed several high resolution masks to perform a versatile micro-fabrication process
to test blood under several scenarios of micro-contractions. I fabricated the moulds used
for the polymer casting process of the device. I tested and implemented ways to fabricate
the reservoirs of the chip. I implemented a process to eliminate debris from the fabrica-
tion process that could clog the micro-contraction. I designed and implemented several
debris traps. post-processing and analysis of µParticle Image Velocimetry experiments. I
performed the blood perfusion experiments and analysis of blood perfusion experiments.
The content of this Chapter has been published in the Journal Lab on a Chip, was
selected for the back cover and ranked as a hot article for the Journal during 2010. It is
presented here with small modifications.
F. J. Tovar-Lopez, G. Rosengarten, E. Westein, K. Khoshmanesh, S. P. Jackson, A. Mitchell,
and W. S. Nesbitt. “A microfluidics device to monitor platelet aggregation dynamics in
response to strain rate micro-gradients in flowing blood., ”Lab Chip, vol. 10, pp. 291–
302, Feb 2010.[4]
5.2 Introduction
Chapter 3 and Chapter 4 have identified that a sudden increase followed by a sudden de-
crease in the strain-rates that the blood is experiencing in the length scale of micrometers
78
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represent a disturbance where an accumulation of platelets was observed even with the
chemical mechanisms of aggregation blocked.
The investigation on Chapter 3 suggested that not only the peak strain-rates experi-
enced by platelets is determinant in platelet response but also the strain-rates history since
platelets can also be exposed to different accelerations and decelerations due to the local
geometry of the stenosis. As in-vivo parameters are highly complex and difficult to con-
trol it was not possible to design an in-vivo experiment to demonstrate the importance of
strain-rate history in platelet response. On the other hand in Chapter 4 it was presented
that a synthetic device modified with a micro-size protrusion was able to generate a sim-
ilar strain-rate history that also trigger thrombus formation. The limitation of only being
able to change the bead diameter produced that some inconsistencies when comparing
beads of different diameters including the inability of choosing an equivalent streamline
from the same point reference, therefore it is difficult to examine the effect of acceleration
and deceleration in isolation from peak strain-rates.
Such limitations serve as a motivation to develop a platform using micro-technologies
to have precise control of the magnitude and duration of the peak strain-rates and also the
rate and duration of the acceleration and deceleration before and after this peak strain-
rate. In this Chapter, by using current micro-fabrication technologies, a way of combine
the previous methods on a mimetic proof of concept platform to emulate and control the
haemodynamics conditions that promote platelet aggregation will be presented.
Progress in micro-technologies has attracted the attention of researchers in several
areas including haemodynamics and thrombosis. Current applications of micro-devices
include lab on a chip applications for clinical diagnostic but also tools for research to
better understand biophysical phenomena of blood flow. Although Lab-on-a-chip based
devices have been applied to the study of platelet adhesion and aggregation in the past,
these methods have either consisted of constant laminar flow systems (constant strain-
rates) incorporating immobilized adhesive proteins such as purified von Willebrand factor
(VWF), or chemically driven aggregation models involving endpoint biochemical analysis
of total platelet-adhesion or aggregate mass [112, 113, 114, 115, 25]. Other microfluidics
devices have been applied to study cellular responses to mechanical forces. A device fab-
ricated by You [116] was used to study the mechanical stimulation of osteocyte processes.
Schaff[117] utilized a chip that provides a vascular mimetic environment of constant shear
stress to study the the leukocyte-endothelial inflammatory response. Rossie[118] fabri-
cated a device that consisted of tapered channels to study the response at sub-cellular
level of endothelial cells to shear flow, characterised with CFD and micro-Particle Image
Velocimetry (µPIV). Park[119] presented a method to study the generation of chemical
concentration and mechanical shear stress gradients in a single microfluidics chip using
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an osmotic pump that produces very slow (a few µm/s) and controlled flow, allowing a
wide and stable diffusion of specific chemical concentration. Chau[120] fabricated a de-
vice that provides an array of different channels that enable the study of cell mechanics
under 10 different constant shear stresses ranging over two orders of magnitude (0.07-13
Pa) simultaneously. Wang[121] presented a method capable of generating variable mag-
nitudes, gradients, and different modes of shear flow, to study sensory and force trans-
duction mechanisms in cells. The chip fabricated allowed the study cell culture under
spatially resolved shear flow conditions as well as study of cell response to shear flow in
real-time. The chip was used to study the effects of shear on cellular functions of Madin-
Darby Canine Kidney (MDCK), renal epithelial cells. Shao[122] utilized an integrated
micro-pump in a chip to study the response of an endothelial cells culture exposed to a
pulsatile and oscillatory shear stress.
The device presented in this Chapter utilizes angular micro-contractions that mimic the
haemodynamics conditions of the stenosis found in micro-vessels, producing a platform
that offers several advantages over these conventional systems, including; dynamic differ-
ential strain-rate control, the ability to achieve discrete periods of highly elevated strain-
rate with minimal sample volume, and the ability to precisely control the spatial loca-
tion and extent of forming aggregates. The latter, in conjunction with the application
of state-of-the-art micro-imaging and spectroscopy based techniques, allows for the real-
time monitoring of platelet functional responses as opposed to more traditional end-point
analyses of aggregate size. This device has been instrumental to replicate under con-
trolled conditions, important in-vivo observations that leaded to the biological discovery
of a new mechanism of platelet aggregation that occurs independent of the commonly ac-
cepted soluble agonists mediated pathways[1], therefore it has been used as a supporting
evidence as well.
This Chapter is organized as follows. Section 5.3 presents the device design and the
micro-fabrication methods used. Section 5.4 presents details of the numerical calcula-
tion of the haemodynamics in straight sections and in the micro-contractions. Section 5.4
presents the experimental characterisation using µParticle Image Velocimetry. Section 5.5
presents a new proof-of-concept blood perfusion experiments that illustrate the versatility
of the device in addressing the basic haemodynamics parameters driving platelet aggre-
gation. A summary of the results and conclusions is presented in Section 5.6.
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5.3 Device Design and Fabrication
5.3.1 Device Design
As it was presented on Chapter 3, the variables of an in-vivo stenosis that impact in the
local haemodynamics are in function of the vessel wall elasticity and needle diameter.
Figure 5.1 presents again the variables of an in-vivo stenosis. By using micro-fabrication
technologies it is possible fabricate micro-channels with accurately and independent con-
trol of these variables on the micron-scale. Because of the fabrication technique the micro-
channels do not have a cylindrical profile but rectangular.
Lc
Ao
Ar
 % Stenosis_Area=
Ao-Ar
Ao
X 100
θc θe
lo: Initial diameter
lr:  closest distance
Ao: Initial area
Ar:  Reduced area
Lc:  Length of contraction
θc:  Angle of contraction
θe:  Angle of expansion
 % Stenosis_linear=
  lo-lr
lo
X 100
lo
lr
Figure 5.1: Variables defining a stenosis.
Figure 5.2 illustrates the overall design of the device, comprising a top polydimethyl-
siloxane (PDMS) chip consisting of; [A] an inlet reservoir of approx. 200µL volume (8
mm diameter) for blood delivery, [B] an upstream trap to prevent fouling of the micro-
channels by particulate matter and/or micro-clots that may have formed in the blood sam-
ple due to inadequate anticoagulation, [C] a feeder channel connecting the trap zone with
the micro-contraction, [D] three replicate high resolution micro-channels with the same
defined strain rate micro-gradient geometry, [E & F] a small bore (1.0 mm) exhaust chan-
nel and a stainless steel outlet connection [F] attached to 10 cm of medical grade Tygon
tubing (0.8 mm I.D/ 1.6 mm O.D) and a Harvard PHD-2000 syringe driver. The PDMS
chip was surface adhered to a 65×22 mm borosilicate #1 microscope cover-glass that
formed the 0.15 mm thick bottom wall of the micro-channel and allowed for both trans-
mitted light and epi-fluorescence imaging at the micro-contraction geometries. Three
symmetric micro-channel design cases were chosen from all possible cases for the proof-
of-concept study (Figure 5.2b). These three cases comprised a fixed stenosis of 80%
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Figure 5.2: Proof of concept device design. (a) Schematics detailing the main components of
the strain rate micro-gradient device (PDMS chip). [A] 200 µL inlet reservoir for blood delivery.
[B] Trap to prevent micro-channel fouling by particulate matter and/or micro-clots in the blood
sample due to inadequate anticoagulation. [C] Feeder channel connecting the trap zone with the
micro-contraction, [D] three replicate high resolution micro-channels with the same defined strain
rate micro-gradient geometry, [E] exhaust channel and [F] outlet connection to the syringe pump.
(b) Schematic showing three proof of concept micro-geometries selected for this study and an
overview of the contraction dimensions within the device; θc= contraction angle at the step wall;
θe= expansion angle at the step wall.
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(area), with different contraction/expansion angles of 30◦, 60◦ and 90◦. In all cases the in-
put and output channel widths were set to 100µm. The contraction angle θc corresponds
to the region of acceleration, the gap distance [g] corresponds to the region of maximum
strain rate and the expansion angle θe corresponds to the zone of deceleration. For this
trial study the length of the contraction was set to 15µm, and the gap distance was set
to 20µm (Figure 5.2b). Based on this nomenclature the three cases utilized in the cur-
rent study were defined as: symmetric 30◦: c30g20e30, symmetric 60◦: c60g20e60 and
symmetric 90◦: c90g20e90. Overall the contraction/expansion angles, degree of stenosis
and input flow rates were chosen to mimic as closely as possible the in-vivo case under
conditions of externally applied stenosis.
5.3.2 Device fabrication
The biomimetic micro-channels were fabricated in (PDMS Sylgard) cast from a patterned
mould realized using standard photo-lithography techniques. A high resolution chrome
mask was used in order to achieve well defined features and straight side walls. A 4 inch
silicon wafer was spin coated with KMPR 1025 (MicroChem Corp.) photo-resist using
a spread cycle of 300 rpm and 100 rpm/s for 10 seconds and a development cycle of
1000 rpm and 300rpm/s for 30 seconds, in order to achieve a film of 100µm thickness
with good uniformity. A cycle of edge bead removal was conducted for 30 seconds using
edge bead removal solvent. The KMPR coated wafer was soft-baked by ramping the
temperature at 6 ◦C/min start ng from 23 ◦C and holding at 10 ◦C for 4 minutes to dry out
the solvents. The KMPR film was exposed with a mask pattern for 2 minutes of UV on
a MJB3 contact mask aligner with a wavelength of 360 nm and a power of 8 mW/cm2,
using 2 exposures of 1 minute each in order to avoid over heating the substrate. After
exposure the patterns were cross linked by baking on a hot-plate for 4 minutes at 10 ◦C,
ramping the temperature at 6 ◦C /min starting from 23 ◦C. The exposed and cross linked
film was cooled down slowly to room temperature with the sample on the hot-plate to
avoid thermal stress on the film and possible cracks due to sudden changes in temperature.
The unexposed KMPR was developed for 12 minutes with periodic agitation to remove
the unexposed material. After developing the KMPR pattern, the wafer was cleaned with
isopropanol and distilled water (DI) and a final hard bake was done by heating the sample
to 120 ◦C for 3 hours, in order to improve and strengthen the cross-linked KMPR pattern
and extend the service life. The KMPR pattern was then ready for use as a mould for
casting PDMS channels. Once the mould was fabricated, PDMS and its curing agent
were mixed at a ratio 10:1 and degassed for 30 minutes. The mixture was poured onto the
KMPR mould previously made and contained within a polymethyl methacrylate (PMMA)
shim. The PDMS was then cured in an oven at 100 ◦C for 20 minutes. The PDMS
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channels were pealed from the KMPR mould and a 8mm inlet reservoir hole was made
using a biopsy punch. For the outlet connection to the syringe pump, a 1mm biopsy punch
was used. After both holes were punched, the PDMS channel was placed directly onto a
65×22mm glass slide. Adhesion was achieved simply due to the low surface energy of
PDMS. Figure 5.3 shows representative images of the fabrication of the device, where it
can be observed the rectangular section of the channel.
a)
b)
c)
Figure 5.3 Fabrication of the device.. (a) Representative KMPR mould on a 4 inch. silicon
wafer. (b) Micro-contractions fabricated. (c) Representative cross-section of the micro-channel.
A rectangle marked on dots is shown for comparison.
5.4 Haemodynamics Characterization of the device
5.4.1 Haemodynamics computations of straight section
According to published data, blood flow in capillary vessels produces strain-rates that
fall between 500 to 5000 s−1, with around 1800 s−1 being a typical reported mean value
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for small arteries/arterioles[123]. As the micro-channels are designed to mimic haemody-
namics in-vivo, the flow rate was adjusted to produce strain-rate close to the mean reported
value. A value of 1800 s−1 was choose as an input value upstream of the contraction. Any
particle travelling close to the mid-plane given by the thickness of the photo resist dimen-
sion will experience a strain-rate with in this range. In order to compute the relationship
between the nominal strain-rate (1800 s−1) with the geometrical variables of the channel
(width and height) the analytical solution of the velocity profile for a Newtonian fluid in
rectangular geometries[108] was used:
Vx(y, z) =
12Q
abpi3
∑
i=1,3,...
−1 i−12
i3
cos( ipiy
2a
)(1− cosh ipiz2a
cosh( ipib
2a
)
)
1− 192a
pi5b
∑
i=1,3,...
tan ipib
2a
i5
(5.1)
In Equation 5.1, Q is the flow rate, a is half the channel height which was fixed at
a = 100µm, and b is half the channel width which is adjustable during the fabrication
process (the width of the channel was given by the thickness of the photo resist); the
direction of the flow is in the x direction and the plane where the micro-geometries are
allocated is xy. Once the dimensions were known the flow rate was adjusted to reach the
target strain-rate (1800 s−1). The laminar shear-rate is obtained once the velocity is calcu-
lated by taking a discrete derivative near the wall. Equation 5.1 is useful for geometries of
constant cross section that produce constant shear-rate. However to compute the haemo-
dynamics of geometries of variable dimension (contraction and expansion zones of the
micro-channels), it was necessary to solve over a number of discrete cells that represent
the volume occupied by the fluid, the continuity and momentum equations Navier-Stokes
Equations 3.1 and 3.2, described in Section 3.4.2.
The geometries of the micro-channels were defined using Gambit 2.2 (Fluent USA,
Lebanon, NH) a d discretized using a mixed mesh. Once the discretized volume was
built, a finite volume scheme using the commercial software (FLUENT 6.0, Fluent USA,
Lebanon, NH) was used in order to solve the Navier-Stokes equations numerically. The
fluid medium was considered homogeneous with a constant density ρ = 998.2 kg
m3
and
constant viscosity of ν = 0.00348Pas. Blood can be approximated as Newtonian fluid at
mid and high strain-rates[75]. The pressure discretization scheme was set as standard and
the second order upwind momentum option was enabled. The boundary condition at the
walls was set as zero velocity to enforce the no slip condition. As the micro geometries
were symmetric in the xy plane, a symmetric condition was implemented. The fully
developed velocity profile given in Equation 5.1 was used as a boundary condition for
the velocity inlet where the channels have a constant cross-section. This significantly
improved the time of convergence of the solution and required only a minimal distance
to obtain a fully developed flow; hence it was possible to use a high density of elements
in the micro-contraction. Under physiological conditions, platelets flowing in blood flow
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are transported to the walls due to lateral displacement by high density erythrocytes [93,
94, 95, 96]. CFD simulations were used to predict steady-state models of streamline
trajectories within 1µm (equivalent to 1
2
discoid platelet diameter) from the step wall and
located at the center of the width of the channel (middle plane of the dimension given by
the thickness of the photo-resist mould).
5.4.2 Haemodynamics computation of micro-contractions
In order to controllably investigate the effects of the acceleration rate, peak strain-rate and
deceleration rate identified as principle geometric parameters from the in-vivo modeling
experiments on platelet functional behavior presented in Chapter 3 a proof-of-concept
micro-channel device was developed composed of a series of side wall geometries that
reflect idealized stages of vessel wall deformation in the in-vivo setting and a series of
more synthetic cases. Figure 5.2c) describes the three symmetric micro-channel design
cases chosen from all possible cases for the proof-of-concept study. Numerical (CFD)
simulations were carried out to predict the velocity field, strain-rate distribution produced,
and to study particle behavior within selected streamlines of blood flow within the device.
Figures 5.4a) and 5.4b) present comparative strain-rate distributions (upstream of con-
traction) for the model blood vessel and the c60g20e60 micro-channel case, respectively.
Note that in the blood vessel case an axisymetric/homogeneous shear-rate distribution is
predicted, however due to the rectangular geometry and low aspect ratio (width/height =
1.3) of the micro-channel case, the shear-rate follows a parabolic distribution along the
side walls, with the maximum at the center of the walls and the lowest values at the corners
as shown in (Figure 5.4b). However, the strain-rate is fairly uniform for a range of heights
from a height of about 30µm above the channel floor (glass cover-slide) to the maximum
at half the cha nel height (at 65µm), as indicated in Figure 5.4b). In this range platelets
will experience approximately uniform strain-rates ranging between 1, 500-1, 960 s−1,
falling well within the nominal physiological range reported for mesenteric arteries and
arterioles[123]. A more homogeneous distribution of shear-rates across the channel could
be achieved by increasing the aspect ratio of the channel (either increasing the width given
by the designed mask or increasing the height, given by the thickness of the photo-resist),
however, this could affect the hydraulic diameter (affecting the Reynolds number at the
contraction and the exposure time of the platelets to the strain-rate gradient). In this inves-
tigation it was of interest to keep the lowest possible Reynolds number at the contraction,
with a similar residence time, to model a high strain-rate zone with similar inertia effects
to the in-vivo case reviewed in Chapter 3 (Reynolds at the in-vivo experiment for a 100µm
arteriole Re=0.53 and in the micro-channel Re=0.67).
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Figure 5.4: Computed strain-rate distributions in the mesenteric arteriole and the c60g20e60 vas-
cular mimetic micro-channel. (a) Computed strain-rate distribution for blood flow in the mouse
mesenteric arteriole (42µm) upstream of stenosis (side-wall compression). Note due to viscous
effects and the cylindrical geometry, a uniform strain-rate at the wall is produced by the fluid flow.
(b) Computed strain-rate distribution color map for blood flow in the c60g20e60 vascular mimetic
upstream of the defined contraction geometry. Note due to the rectangular channel geometry and
low aspect ratio the flow inside the micro channel produces a parabolic distribution along the
walls, with strain-rate maxima at the center and minima at the corner edges. A plane located at
30µm from the cover-slip was chosen for all imaging experiments such that fluid and particles at
this location experience strain-rates in the order of 1700 s−1, with maxima at the 65µmmid-plane
exhibiting strain-rates approaching 1960 s−1. (c) Computed strain-rate distribution color map for
blood flow in the mouse mesenteric arteriole at a stenosis of 80% area. The geometry of the blood
vessel in the contraction zone is imposed by the combination of the shape of the blunted needle
and elastic effects of the vessel side-wall. An irregular surface topography is produced which
creates a heterogeneous strain-rate distribution in 3-dimensions, with two peaks of 44600−1 that
rapidly decrease approaching the expansion zone. (d) Computed strain-rate distribution color map
for blood flow in the c60g20e60 vascular mimetic at the defined contraction geometry. Note that
in the vascular mimetic a bigger aspect ratio is produced resulting in a more homogeneous strain-
rate distribution. The streamlines shown represent the computed trajectories for particles traveling
at 1µm (12 platelet diameter) from the micro-channel wall; note that at this distance, a maxima
of 41200−1 is generated, although higher strain-rates may be experienced at the wall, where flow
velocity is zero.
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Figures 5.4c) and 5.4d) present the computed results for the strain-rate distributions
within the contraction zone for the model arteriole (80% stenosis) and c60g20e60 micro-
channel, respectively. Note that in the vessel case, the non-uniform nature of the micro-
needle compression results in an uneven side-wall topography producing an irregular dis-
tribution of strain-rate, with two local regions of high shear ( 44,600 s−1) positioned at
the upstream and downstream edges of the contraction zone as shown in Figure 5.4c).
In contrast, a key advantage of the synthetic c60g20e60 micro-channel case is that the
geometric shape of the contraction is uniform (with a larger aspect ratio) resulting in a
more homogeneous strain-rate distribution as shown in Figure 5.4d). Furthermore, Fig-
ure 5.4 demonstrates, that for flow streamlines at 1µm from the c60g20e60 micro-channel
wall, platelets will experience a predicted peak strain-rate at the center of the contraction
geometry of 41,200 s−1 that closely approximates the blood vessel case. Overall the
simulations suggest that the c60g20e60 micro channel case represents a good idealized
approximation of the haemodynamics conditions generated within the in-vivo model of
Chapter 3.
A principle aim of the device design concept was the ability to introduce precisely
controlled changes in key haemodynamics variables and explore the subsequent effects
on platelet aggregation dynamics. Figure 5.5a) presents comparative strain-rate contour
plots for the three micro-channel geometries selected for this study that comprise sym-
metric changes in contraction and expansion geometry with constant stenosis (80% area).
This analysis demonstrates that overall modification of the contraction and expansion an-
gles has a significant effect on the overall strain-rate distribution in the flow. In order to
gain more insight into the effect of the changing geometry on the strain-rate history of
single platelets travelling through the contraction zone the particle (platelet) flow stream-
lines within 1µm (1
2
platelet diameter) of the step-wall over both time and length were
modelled as a function of contraction and expansion angle. Figure 5.5b) and c) present
the strain-rate calculation for angles of 30◦, 60◦, and 90◦ as a function of time and space
respectively. Significantly, all three cases follow temporal and magnitude changes in
strain-rate that conform closely to the in-vivo vessel analysis of strain-rate history for the
80% stenosis case. The key characteristics are that platelets flow in from the constant
(straight) upstream segment (1500s−1 - 1900s−1), experience an acceleration through the
contraction segments lasting a few milliseconds and rapidly reach a zone of peak strain-
rate approaching 41, 000s−1 (Figure 5.5b).
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Figure 5.5: haemodynamics performance of the device. (a) Contour plots of the predicted strain-
rate distributions for the c30g20e30, c60g20e60 and c90g20e90 vascular mimetic. Note that the
reduction of the hydraulic area produces a progressive increase/decrease of the deformation rates
of the fluid, going from zones of dark blue (lowest values) to zones of red (highest values), how-
ever, the rate of the progressive increase/decrease is different for each geometry. (b) CFD plots
demonstrating the predicted strain-rate history experienced by a model platelet traveling at 1µm
from the step wall for the three designated micro-channel geometries as a function of time. (c)
CFD plots demonstrating the predicted strain-rate history experienced by a model platelet trav-
eling at 1µm from the step wall for the three designated micro-channel geometries as a function
distance. The 0 µm reference point is located at the mid-line of the defined contraction geome-
tries. (d) CFD plots showing a comparison of the strain-rate gradient experienced at 10µm and 30
30µm from the mid-line of the defined contraction geometries following a streamline 1µm from
the step wall.
A key haemodynamics variable that can be controlled by changing the expansion an-
gles through in these proof-of-concept geometries was the overall deceleration rate expe-
rienced by platelets that initially tether within the contraction zone. Figure 5.5c), shows
an analysis of the effect of expansion angle on the strain-rate deceleration experienced by
a platelet as it transitions into the expansions for the three micro-channel cases. Exami-
nation of the instantaneous values of strain-rate experienced by a platelet 1µm from the
step-wall at 10µm and 30µm from the center of the contraction zone (peak phase) demon-
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strates that a platelet experiences significant differences in the magnitude of strain-rate
deceleration as a function of the three angles over an equivalent distance, such that; a θe =
30◦ results in a 35% (41, 000 - 28, 000s−1) reduction, a θe = 60◦ results in a 46% reduction
(41, 000 - 22, 200s−1), and a θe = 90◦ results in a 65% reduction (41, 000 - 14, 400s−1)
in strain-rate over the first 10µm of the expansion zone (Figure 5.5). Taken together, the
CFD analyses of strain-rate distributions and single platelet trajectories demonstrates the
overall ability of the device design to precisely and independently control and signifi-
cantly modify discrete aspects of the strain-rate micro-gradient imposed on flowing blood
and to generate haemodynamics conditions that represent idealized and more synthetic
versions of the blood flow dynamics generated in the published in-vivo stenosis model of
platelet aggregation [1].
5.4.3 Experimental Characteristation of the device
In order to be confident that the predictions from CFD would be an accurate representa-
tion of the real fluid dynamics observed in the practically realized micro-contractions, it
was necessary to characterise the flow within the fabricated device directly using micro
resolution particle image velocimetry (µPIV). Due to technical limitations of the µPIV
apparatus a low velocity (0.08 µL/min) approach was used and the findings compared to
low velocity CFD predictions and extrapolated to the high velocity scenario utilized in the
blood flow studies. This assumption was taken to be valid as at no point in the blood flow
experiments were regions of flow separation or recirculation observed. Thus for the CFD
simulations, the distribution of the velocity field and strain-rates at low and high flow rates
were assumed to be the same, differing only in magnitude. A constant displacement rate
syringe pump (Harvard Apparatus PHD-2000) was used to impose the flow rate, using a
25 µL Hamilto Gastight syringe. Before connecting the syringe into the chip, care was
taken to purge all the air in the fluidic line in order to have more control on the small
amount of volume displaced.
µPIV Set up
Figure 5.6 presents a photograph of the micro-fluidic chip mounted in the µPIV system.
The low velocity µPIV system was composed of a back-lit light emitting diode configu-
ration (LED 525 nm) flasher (LaVision GmbH, Gottingen) exciting 1µm diameter tracer
particles (Duke Scientific Corp) in deionized water as the working fluid. A CCD camera
(LaVision Systems) of 1376×1024 pixel resolution connected to an inverted microscope
(Nikon TE2000-U) with 60× (NA = 1.25) was configured to capture 200 image pairs from
the particle flow streamlines. The viscosity of the bead suspension was µ = 0.94×103Pas
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and the density was ρ = 998.2 kg
m3
. The flow rate range was determined by the limitations
of the CCD frame rate and available light budget with the maximum measurable range
of velocities between Q = 0.01-1 µL/min. An objective lens of and 60× (NA =1.25 oil
immersed) was used to acquire the images in specific xy planes.
Compared to a standard PIV laser system, the LED system has several advantages in-
cluding small size, adaptability to different fluorescent dyes (due the range of wavelength
available), incoherent light (no speckle or interference phenomena), freely adjustable
pulse length and repetition rate, low energy consumption and very low cost. The main
disadvantages are the lower light intensity, the broad wavelength spectrum and a broad
spatial radiation pattern. Because of the back-light configuration, the correlation in the
µPIV was done using the shadows of the particles, hence the fluorescent property of the
particles is not needed for the velocimetry measurements, however the fluorescence was
useful to find the channel and focus the particles since the pathway of the light of the
inverted microscope was blocked by the LED flasher, which should be positioned on the
micro-fluidic chip as shown in Figure 5.6.
Figure 5.6: Experimental set up of the µPIV. Observe that the led flasher needs to be situated
exactly over the sample.
The LED was powered and controlled by a PIV timing system (Lavision Systems).
The minimum pulse length of the LED corresponds to the minimum trigger pulse length
and an additional fall time, this resulted in a minimal pulse of 8 ms. Image acquisition
was performed on a PC with Davis Software (Lavision Systems). A minimum of 200
image pairs were recorded. These images were processed and ensemble averaged using
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Davis software. The final image was produced in Matlab (Mathworks Inc.).
Vector calculation
Taking into account the flow-rate and viewing the optimization of the signal-to-noise ratio,
a time delay between LED flasher pulses ranging from 100 to 500 ms and a repetition
rate of 4.9 Hz were used to have a maximum particles displacement of approximately
1 to 4 times of the interrogation area length. In order to improve the resolution of the
measurements, a multi-pass iteration was employed which comprised the steps described
as follows. Interrogation areas of 32x32 pixels with 50% overlap in both stream-wise and
crosswise directions were used. This determined the initial grid size of the vector field,
resulting in an initial distance between individual vectors of 16 pixels. The multi-pass
iteration defined the final grid size and it was performed decreasing the windows down to
8×8 pixels. The computed vector field information in the first pass (windows of 32×32
pixels) was used as reference vector field for the next pass. Using the information of
the previous pass, the position of the interrogation windows in the new pass was shifted
according the determined particle image shift. This helps to correlate the correct particles
and improved the signal to noise ratio. In the next pass the window size is half the size
of the previous pass and the vector calculated in the first pass was used as a best-choice
window shift. In this manner, the window shift is adaptively improved to compute the
vectors in the following steps with more accuracy. This ensured the same particles were
correlated with each other. This multi-pass with decreasing window procedure resulted
in having a much smaller final interrogation window size. This improved the spatial
resolution of the vector field since a smaller grid size of the vector field was achieved, and
it produces less erroneous vectors.
Scaling
The time between frames was adjusted according to the minimum pulse length of the LED
flasher. Even though the minimum pulse length of the LED flasher was 8µs, previous
experience with the particle illumination setup suggested that 30µs was a proper time
for get a good contrast of the particle shadows with the optical set up used. Using this
restriction the minimum time between frames was on the order of 100µs. Based on this
limitation the flow rate was adjusted to observe congruent vectors. The pulse length of
the LED needed to be adjusted to at least 200µs since a good contrast/illumination was
needed since a 60× objective was used. This resulted in a scaling factor for this setup and
magnification of 240 times (0.06 µL/min vs 16 µL/min).
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Velocity Profile Prediction vs Experiment: Micro-contraction at 0.06 µL/min with
60× magnification
The next step in experimentally characterizing the platform was to compare the experi-
mentally measured flow in the micro-contraction to that predicted by computational fluid
dynamics. At the narrowest point, the micro-contraction is only 20µm wide, this is 5
times narrower than the straight channel examined in the previous section. It was thus
necessary to increase the magnification from 10× to 60× and to reduce the flow rate from
4µL/min to 0.06µL/min in order to make accurate measurements with the µPIV sys-
tem. Using these conditions the µPIV system was used to measure the velocity profile of
the c90g20e90 micro-contraction.
Figure 5.7a) presents the measured flow velocity profile for the c90g20e90 micro-
contraction with 60× magnification and a flow rate of 0.06µL/min. The velocity vectors
measured using µPIV are also presented in Figure 5.7a) as arrows. Figure 5.7b) presents
the same velocity profile information presented in Figure 5.7a) but with the µPIV mea-
sured velocity profile presented as a three dimensional colored surface plot and the com-
putational fluid dynamics simulations presented as black lines at a sequence of points
along the contraction. This plot allows quantitative comparison of the µPIV measured
and computational fluid dynamics simulation. It is clear that the magnitude of veloc-
ity predicted at all points along the contraction are in good agreement with the µPIV
measured velocities. Figure 5.7c) presents the µPIV measured velocity profile from two
cross-sections along the length of the contraction. The location of these cross-sections
are chosen at 8µm and 25µm from the minimum gap. The velocity profile predicted from
computational fluid dynamic simulations is also presented. It is clear from this plot that
the agreement between the µPIV measurement and the computational simulation is very
good indeed.
The 3D vector velocity field of Figure 5.7a) was used also to calculate streamlines
that fluid elements would take when flowing through the geometry. Figure 5.7d) shows
the streamlines calculated from the µPIV experiments. The results of Figure 5.7 shows
that the measured performance of the realized micro-contraction geometry and the per-
formance predicted by computational fluid dynamics of the nominal geometry profile are
in very good agreement. From this it can be concluded that the geometry of the realized
micro-channel was very close to the nominal geometry designed and also that the com-
putational fluid dynamics can provide an excellent prediction of the fluid dynamics that
would actually be observed in such a channel.
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Figure 5.7: Experimental characterisation of the micro-contraction. a) Velocity contour plot from
the measurement at the micro-contraction at the middle plane (yz). b) Velocity profile obtained
using µPIV (contour mesh) and velocity profiles across the c90g20e90 micro-channel case at dif-
ferent sections obtained using CFD (black lines) at 0.06µL/min. The fluid flow experiences an
acceleration into the contraction reaching its maximum value (red zone) and rapidly experiences
a deceleration into the expansion. These rapid changes in velocity occurring in tenths of microm-
eters produce small regions of high deformation rates that define the strain-rate micro-gradient.
c) Velocity profiles comparison in 2D at 8µm (maximum of 900mms ) and 25µm (maximum of
300mms ) from the contraction. Note the parabolic shape of the velocity profile with some de-
gree of asymmetry due to the differences in velocity imposed by the asymmetric contraction. d)
Predicted streamlines calculated from the µPIV experiments that fluid elements follow.
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5.5 Micro-device performance as a platform to study platelet
aggregation
Having demonstrated in Section 5.4.3 that the micro-channels can be realized precisely
and provide a fluid dynamic environment very close to that predicted by computational
fluid dynamics, it is now possible to explore the use of these microfluidic channels as a
platform for studying platelet aggregation.
To ascertain the effectiveness of the device design to focally promote platelet aggre-
gation and mimic the in-vivo observations a series of whole blood perfusion experiments
were carried out. In order to isolate the mechanical effects of blood flow from the well ac-
cepted platelet activation effects of the soluble chemical agonists ADP, TXA2 and throm-
bin, all experiments were performed in the presence of pharmacological inhibitors of the
canonical platelet amplification loops (Amplification Loop Blockade [ALB]).
5.5.1 Device Operation
Blood perfusion studies through the device were carried out at the Australian Centre
for Blood Diseases, Monash University, using hirudin (800 U/ml) anti-coagulated whole
blood, taken from consenting human donors. Approval for these studies was obtained
from the Monash University Standing Committee on Ethics in Research Involving Hu-
mans. Whole blood samples were incubated at 37 ◦C for 10 minutes with the lipophylic
membrane dye DiOC6 (1ug/ml) [Molecular Probes]. Flow in the device was induced by a
Harvard PHD-2000 syringe driver connected to the outlet channel in the PDMS block us-
ing a Becton Dickinson 5ml glass syringe attached to 10cm of Tygon (0.8mm I.D.) tubing.
Blood samples were introduced into the micro-channels via the 200µL reservoir cut into
the PDMS block at the channel inlet (Figure 5.2). Prior to sample perfusion, degassed
Tyrodes buffer (4.3 mM K2HPO4, 4.3 mM Na2HPO4, 24.3 mM NaH2PO4, 113 mM
NaCl, 5.5 mM D-glucose, pH 7.2) at a temperature of 45 ◦C was used to prime the chan-
nels to remove any air bubbles. Platelet aggregation was monitored via epi-fluorescence
illumination (Sutter DG4 Xenon arc lamp [488nm] light source) using an Olympus IX81
invert microscope with a UAPO 40× OI3/340 objective and attached Hamamatsu Orca
ER CCD with an exposure time of 80ms. Image acquisition was controlled through Meta-
morph 6.0 (multi-dimension acquisition). Blood flow was observed within a focal plane
approximately 30 µm above the cover-slip wall of the channels to avoid side wall effects
on platelet behavior (see section 5.4.2). Fluorescently labeled platelet aggregates were
segmented via intensity thresholding and the threshold area determined on a frame by
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frame basis in Metamorph 6.0. In the case of straight micro-channels, endpoint mean
surface areas were determined from 10 random fields-of-view covering the full length of
the micro-channels. Figure 5.8 shows a representative chip in operation.
Figure 5.8: Operation of the device with human blood.
5.5.2 Platelet aggregation as a function of micro-channel design
Figure 5.9 presents real time epi-fluorescence imaging of DiOC6 labeled whole blood
perfusion at a constant flow rate of 16µL/min (input strain-rate = 1,800 s−1) through
the c60g20e60 geometric case over a 10 min time-frame, following pretreatment for
10 minute with the platelet inhibitors; apyrase (0.02 U/ml), MRS2179 (100 µM) and
2-MeSAMP (10 µM) — to block ADP; Indomethacin (10 µM) — to block thrombox-
ane(TXA2); and hirudin (800 U/ml) — to block thrombin. Perfusion through the c60g20e60
micro-channel resulted in robust platelet aggregation that initiated specifically at the down-
stream edge of the peak strain-rate (contraction) zone (Fig 5.10a; yellow arrow). Sig-
nificantly, as was the case in vivo, platelet aggregation occurred progressively within
the downstream strain-rate deceleration (expansion) zone resulting in the formation of a
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relatively large and stable platelet aggregate as shown in Figure 5.9 and Figure 5.10a).
Comparison across three independent donor samples showed tight agreement in terms of
overall aggregation dynamics and time to occlusion (Figure 5.9).
540 sc60 g20 e60
0 s 60 s 180 s 540 s360 s
a)
Figure 5.9: Proof-of-concept blood flow experiments I. (a) Representative epi-fluorescence image
sequence of ALB blood perfusion through the c60g20e60 micro-channel case; the yellow arrow
denotes the point of initial aggregation [t=0 s], the white arrow designates the direction of blood
flow (scale bar=15 µm) [representative of n=3 experiments]
To investigate the platelet adhesion receptors mediating the aggregation response in
the device, whole blood samples were pretreated with the anti-integrin αIIbβ3 Fab c7E3
(20µg/ml) to block the platelet integrin αIIbβ3 or the anti-GPIb IgG Alma12 (50µg/ml)
to block platelet GPIb/V/IX engagement of vWF. Figure 5.10a) demonstrates that in the
presence of either integrin or GPIb blockade, platelet aggregation within the c60g20e60
case was completely inhibited, demonstrating a critical requirement for these primary
platelet adhesion receptors in the aggregation process.
This proof-of-concept data demonstrates that the device design is capable of eliciting
stabilized platelet aggregation mirroring that observed in the in-vivo stenosis experi-
ments and that the introduction of the defined strain-rate micro-gradient imposed by the
c60g20e60 geometry can focally induce stabilized integrin dependent platelet aggregation
in a highly controlled manner. Furthermore, this data supports the findings of Chapter 3
that imposed strain-rate micro-gradients can induce stabilized platelet aggregation inde-
pendent of soluble agonists.
5.5.3 Platelet aggregation at steady-state strain-rate
A large number of published studies utilizing steady-state laminar shear-rate regimes have
identified a direct link between elevated (pathological) shear-rate and increasing levels of
platelet activation and resultant aggregation. It could be argued that the aggregation re-
sponse observed in the prototype device is entirely due to the peak strain-rate generated
at the apex of the c60g20e60 geometry rather than as a result of a dynamic strain-rate
imposed on the blood flow. To investigate this possibility a series of control steady-state
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a) b)
Figure 5.10: Proof-of-concept blood flow experiments I. (a) Representative aggregation traces
showing the response of whole blood perfusion through the c60g20e60 micro-channel case;
c60g20e60-hirudin-anti-coagulated whole blood treated for 10 min with the platelet amplifica-
tion loop blockers (ALB); apyrase (0.02 U ml −1), MRS2179 (100 mM) and 2-MeSAMP (10
mM)— to block ADP; indomethacin (10 mM)— to block TXA2; and hirudin (800 U ml −1)—
to block thrombin (ALB) whole blood perfusion at an input (pre-stenosis) shear rate of 1800 s−1
(n = 3 experiments); α − αIIbβ3 Fab c7E3-ALB whole blood treated for 10 min with 20 mg ml
−1 c7E3 Fab prior to blood perfusion to block integrin αIIbβ3 engagement (n=3 experiments);
αGPIb/V/IX igG Alma12-ALB whole blood treated for 10 min with 50 mg ml −1 of the gly-
coprotein Ib blocking IgG Alma12 (n=3 experiments). (b) Histogram showing mean aggregate
size (µm2) following 10 min of ALB blood perfusion at a pre-contraction strain-rate of 1800 s−1
through control c60g20e60 microchannels versus straight microchannels at 1800, 10 000, 20 000
and 40 000 s−1 strain-rate (n = 3 experiments).
flow experiments in straight (100 x 20µm) micro-channels as a function of increasing
strain-rate were conducted. Perfusion of ALB whole blood at steady-state strain-rates
of 1,800 s−1, 10,000 s−1, 20,000 s−1, and 40,000 s−1 demonstrated that at or below a
threshold strain-rate of 20, 000 s−1 no overt platelet aggregation occurred within the de-
vice (Fig 5.10c). A constant strain-rate of 40,000 s−1, equivalent to that experienced at the
peak of the c60g20e60 contraction zone, resulted in the slow formation of small highly
unstable rolling mini-aggregates (1-3 platelets) that traversed the micro channel walls.
Unlike the c60g20e60 case, these aggregates were randomly distributed and tended to
rapidly disaggregate under flow. This data clearly demonstrates that the stabilized aggre-
gation response observed in the c60g20e60 case is not simply a product of the elevated
strain-rate achieved at the stenosis apex but is a result of the combined effect of accelera-
tion and the coupled zone of decelerating strain-rate.
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5.5.4 Modulation of platelet aggregation as a function of micro chan-
nel geometry
As identified in Section 5.4.2 a chief aim of the device design concept was the ability to
controllably modulate platelet aggregation by modifying key geometric parameters and
therefore the magnitude and extent of the imposed dynamic strain-rate. Figures 5.11
shows a series of test-case experiments in which both the contraction and expansion an-
gles of the micro channel geometry were symmetrically modified as per Section 5.4.2.
 
0 s 60 s 180 s 540 s360 s
0 s 60 s 180 s 540 s360 s
c90 g20 e90
c30 g20 e30
Figure 5.11: Proof-of-concept blood flow experiments II. Representative epi-fluorescence image
sequences of blood perfusion through the c90g20e90 and c30g20e30 micro channel cases; the
yellow arrows denote the points of initial aggregation [t = 0 s], the white arrows designate the
direction of blood flow (scale bar = 15 µm) [representative of n = 3 experiments]. Note that in all
cases the blood samples were pretreated with amplification loop blockers (ALB); apyrase (0.02 U
ml −1), MRS2179 (100 µM) and 2-MeSAMP (10 µM); indomethacin (10 mM) and hirudin (800
U ml −1) for 10 min prior to perfusion (representative of n = 3 experiments for each mimetic).
Figures 5.12 presents a comparison of the aggregation traces for the c60g20e60 test-
case and the c90g20e90 test-case and demonstrates no appreciable difference in the over-
all magnitude of platelet aggregation, where the input pre-stenosis strain-rate was kept
constant at 1,800 s−1. However, the c90g20e90 geometry did result in an increased sta-
bility of the formed aggregates highlighted by the overall reduction in the variation of
aggregate size over time.
In contrast a reduction in contraction and expansion angles from 60◦ to 30◦ (c30g20e30
case) significantly reduced both the initial rate and magnitude of platelet aggregation as
shown in Figure 5.11. Interestingly Figure 5.11 shows that the site of initial platelet aggre-
gation was shifted in the c30g20e30 case downstream from the stenosis apex, suggesting
that an overall strain-rate deceleration must be achieved before significant stabilization of
platelet aggregation can occur (Fig 5.11).
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Figure 5.12: Proof-of-concept blood flow experiments II. (b) Representative aggregation traces
showing the response of ALB treated whole blood perfusion through the c60g20e60, c90g20e90
and c30g20e30 micro channel cases (n = 3 experiments).
Figure 5.13 presents a summary of the strain-rate distribution calculated for each
geometry using CFD and its correspondent fluorescence image from the experiments with
blood. Based on the current working hypothesis and the detailed CFD simulations, the
inability of the c30g20e30 case to support stable platelet aggregation could be explained
by the overall higher strain-rates experienced by the developing aggregate (as it is forced
to develop within higher velocity regions of the flow therefore platelets can not stand
higher drag forces) and the overall reduction in the rate of change in strain-rate within
the expansion zone. In contrast, the increase in aggregate stability in the c90g20e90
case could be explained by more rapid strain-rate deceleration and the protection of the
formed aggregate from the higher velocity regions of the flow. This proof of concept study
clearly demonstrates that modification of the strain-rate geometry and resultant strain-rate
distribution (see Section 5.4.2) in the prototype device can be directly used to modulate
platelet aggregation dynamics in a controlled way.
5.5.5 Recirculation test
Most research to date on blood associate thrombus formation with the recirculation and
eddy formation. To demonstrate that the platelet aggregation produced by this platform
is not associated with recirculation, the geometries were simulated with a sequence of
increasing flow rates. Figure 5.14 presents the flow behavior in the 90◦ geometry with
flow rates of 16, 19, 29, 48, 64 and 91µL/min. It can be observed that for the condi-
tions of operation of the device (Q = 16µL/min) no flow recirculation exists at the zone
of the contraction. A recirculation zone becomes evident downstream the contraction at
Q = 48µL/min, which is around three times faster the experimental conditions. Further-
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Figure 5.13: Comparison of CFD simulations on micro-contractions and fluorescence images
from blood experiments.. (a) Contour plots of the predicted strain-rate distributions for the
c30g20e30, c60g20e60 and c90g20e90 vascular mimetics. Note that the reduction of the hy-
draulic area produces a progressive increase/decrease of the deformation rates of the fluid, going
from zones of dark blue (lowest values) to zones of red (highest values), however, the rate of the
progressive increase/decrease is different for each geometry. (b) CFD plots demonstrating the
predicted strain-rate history experienced by a model platelet traveling at 1µm from the step wall
for the three designated microchannel geometries as a function of time. (c) CFD plots demon-
strating the predicted strain-rate history experienced by a model platelet traveling at 1µm from
the step wall for the three designated microchannel geometries as a function distance. The 0 µm
reference point is located at the mid-line of the defined contraction geometries. (d) CFD plots
showing a comparison of the strain-rate gradient experienced at 10µm and 30 30µm from the
mid-line of the defined contraction geometries following a streamline 1µm from the step wall.
(e)Representative aggregation traces showing the response of ALB treated whole blood perfusion
through the c60g20e60, c90g20e90 and c30g20e30 micro channel cases (n = 3 experiments).
more, as it will was shown in the biological experiments, this recirculation zone does not
correspond with the zone where platelets start to aggregate. Figure 5.15 presents the same
study but for the 60◦ geometry. It can be observed that flow recirculation is not observed
until Q = 91µL/min. This evidently shows that the recirculation is not only dependant
on the inertial forces but also on the geometry.
Both geometries, the 60◦ and 90◦ do not exhibit aggregation even at Q = 16µL/min
and hence it can be concluded that the observed aggregation is not due to flow recircula-
tion. The fact that there is no recirculation in the zone of aggregation for the flow rates
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used in the experiments, clearly demonstrates an important novel aspect of this platform
since this suggest that the aggregation is due to a biophysical phenomena no-related with
recirculation.
Comparing the measurement of Figure 5.7d) from Section 5.4.3 and the simulated
streamlines of Figure 5.15 it can be observed that good qualitative agreement is again
evident.
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Figure 5.14: Assessment of no-recirculation for the 90 degrees geometry at different Reynolds
numbers.
Figure 5.16 presents a summary of the recirculation test using numerical simulations
(CFD) and the aggregation images from blood experiments. It is evident that under the
conditions of the experiment no recirculation was found. For an hypothetical recircula-
tion at high Reynolds number, the zone of recirculation is different to the zone of initial
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Q= 29.4  µL/min  Reynolds = 1.38 Q= 48  µL/min  Reynolds = 2.08
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Figure 5.15: Assessment of no-recirculation for the 90 degrees geometry at different Reynolds
numbers.
aggregation (yellow arrow).
5.6 Conclusions
The device described in this Chapter 5 provides a method for controllably manipulating
blood strain rates at the micron scale while monitoring platelet aggregation dynamics.
Advances in micro-fabrication in combination with detailed numerical analyses of blood
flow have enabled the development of a micro-vascular mimetic design that closely re-
produces the haemodynamics and platelet aggregation dynamics observed in intra-vital
mouse models of acute vascular stenosis. The presented proof-of-concept data demon-
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Figure 5.16: Summary of the test of no-recirculation and platelet aggregation experiments.(a) and
(d) Representative epi-fluorescence image sequences of blood perfusion through the c60g20e60
and c90g20e90 micro channel cases respectively; the yellow arrows denote the points of initial
aggregation [t = 0 s], the white arrows designate the direction of blood flow (scale bar = 15µm).
[representative of n = 3 experiments]. Note that in all cases the blood samples were pretreated
with amplification loop blockers (ALB); apyrase, MRS2179 and 2-MeSAMP); indomethacin and
hirudin for 10 min prior to perfusion (representative of n = 3 experiments for each mimetic).(b)
and (e) Streamlines of the flow at the Reynolds number of the experiment for c60g20e60 and
c90g20e90 micro channel cases respectively. (c) and (f) Streamlines of the flow at a typical
Reynolds number where flow recirculation was found numerically for an homogeneous fluid for
c60g20e60 and c90g20e90 micro channel cases respectively. Note that the zone of recirculation is
different to the zone of initial aggregation ( yellow arrow).
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strates that the device has particular utility to explore different scenarios of controllable
strain rate conditions and should enable a detailed investigation of the role of specific
haemodynamics variables regulating platelet aggregation. Lab on chip based devices
have been applied to the study of platelet adhesion and aggregation in the past, how-
ever these methods have either consisted of constant laminar flow systems incorporating
immobilized adhesive proteins such as purified von Willebrand factor (VWF), or chemi-
cally driven aggregation models involving endpoint biochemical analysis of total platelet-
adhesion or aggregate mass[112, 113, 114, 115, 25]. The application of controlled strain
rate micro-gradients inherent in the presented device design offers several advantages over
these conventional systems, including; dynamic differential strain-rate control, the ability
to achieve discrete periods of highly elevated strain rate with minimal sample volume,
and the ability to precisely control the spatial location and extent of forming aggregates.
The latter, in conjunction with the application of state-of-the-art micro-imaging and spec-
troscopy based techniques, allows for the real-time monitoring of platelet functional re-
sponses as opposed to more traditional end-point analyses of aggregate size. In the in vivo
setting a contributing factor to strain rate micro-gradient induced platelet aggregation is
the requirement for prior vessel wall damage and the exposure of adhesive sub-endothelial
matrix proteins[1]. PDMS in the absence of oxygen plasma treatment has a highly hy-
drophobic character that has a demonstrated propensity to adsorb blood proteins such as
fibrinogen and albumin[124, 125, 126, 127, 128]. Therefore, an undefined variable in-
herent in the PDMS micro device presented is the role of adhesive blood proteins and
platelet adhesion receptors in mediating platelet aggregation in the presented device. It is
conceivable that platelet aggregation under the influence of the imposed strain-rate micro-
gradient is the result of a two stage process involving:
i.the advective transport of plasma proteins to the PDMS boundary layer, triggering initial
primary platelet adhesion and,
ii.the mechanical effects of the applied strain rate micro-gradient on platelet-platelet co-
hesive interactions.
Preliminary studies in which the PDMS chip was saturated with bovine serum albumin
to prevent plasma protein adsorption during blood perfusion suggest that adsorption of
one or more blood plasma proteins is an absolute requirement for platelet aggregation
in the presented device. However, observations on constant shear rate PDMS micro-
channels (section 5.5.3) demonstrate that blood protein adsorption per se is insufficient
to induce platelet aggregation in the absence of an applied strain rate micro-gradient. In-
vestigations examining the adsorption of blood proteins to artificial polymers such as
PDMS have identified a hierarchy of preferential protein adsorption (the Vroman ef-
fect) characterised by the preferential binding of albumin, followed by IgG followed
by fibrinogen, however to date no studies have investigated the place of VWF in this
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hierarchy[129, 130, 131, 132, 133]. Further studies need to be carried out to identify the
specific plasma protein components and the overall effect of strain rate micro-gradients
on the Vroman effect and its impact on aggregation kinetics within the presented micro-
fabricated device. Another key variable that may have a significant impact on platelet
aggregation dynamics in the device is the secretion of soluble platelet agonists such as
ADP and TXA2 under the influence of applied shear stress. Although recently published
studies and the new experiments presented in this Chapter 5 suggest that strain rate micro-
gradient mediated aggregation can occur in the absence of platelet amplification loops, it
is conceivable that different device geometries and therefore different strain rate micro-
gradients may display a differential requirement for chemical platelet activators. Future
studies involving a broader range of strain rate micro-gradient geometries in combina-
tion with pharmacological inhibitors and transgenic animal models will be conducted to
explore in detail the possible synergistic interactions of haemodynamics parameters and
specific chemical agonists that are known to stabilize platelet aggregate formation. Com-
putational Fluid Dynamic analyses were a fundamental tool utilized in the micro-channel
design process.
The application of microfluidics technology has enabled the examination under con-
trolled conditions of the impact of haemodynamics at the micro-scale on platelet function.
In the same manner during the development of this platform, the utilization of a high res-
olution chrome mask as part of the photo-lithographic fabrication process allowed to gen-
erate micro-channels of high resolution, however the ability of even micron-scaled devi-
ations to potentially impact on the platelet aggregation process requires a close to perfect
fabrication procedure, with little margin for error. To achieve the tolerances needed, a
high degree of quality control is required at each stage of the photo-lithographic process.
As an example of this, sharply defined corners were part of the preliminary design how-
ever due to current limitations in the fabrication process; rounded corners were produced
on the order of a 5µm radius (which was a consideration in the CFD model). Although
this limitation did not grossly impact on the platelet response, further refinement of the
fabrication method may ultimately result in more precise control of the haemodynamics
and resultant platelet aggregation. Although PDMS offers many advantages in terms of
cost and ease of fabrication, other materials that allow for more precise geometries may
prove to be advantageous.
On the same manner, during the development of the experiments it was found that there
exists small changes in the dimensions from chip to chip even fabricated from the same
mould. A characterisation on the dimensional changes of PDMS due to moisture absorp-
tion is recommended.
Overall the platform technology presented highlights the advantages of microfluidics
::::
::::
::::
: O
nli
ne
Pu
bli
c V
ers
ion
. F
ran
cis
co
J.
To
va
r-L
op
ez
. R
M
IT
. A
pri
l 2
01
1 :
::::
::::
::::
CHAPTER 5. 107
and lab on chip devices to study platelet function in response to local changes in strain rate
micro-gradients emulating those found in the vasculature. Once fully characterised this
platform technology should show considerable utility as a clinical and research tool in the
diagnosis of platelet functional defects in patients experiencing bleeding or thrombotic
diathesis and also in the screening and development of more effective anti-platelet agents
targeting shear-dependent platelet activation mechanisms.
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Conclusions
The main contribution of this work was building the supporting evidence from the engi-
neering perspective through creation of the device concept, through simulations, fabrica-
tion of a platform which enabled proof of the claim that fluid forces are by themselves able
to produce platelet aggregation and thrombus formation independently of bio-chemical
mechanisms. The current research on thrombosis and platelet aggregation, assumes that
platelets aggregate by a direct accumulation of soluble agonists (chemical factors) at sites
of flow disturbance. It was demonstrated in a synthetic device created as part of this the-
sis that even with the chemical mechanisms blocked, a localised thrombus as a function
of the micro-channel geometry on controlled fluid strain-rate environment was formed,
which was in agreement with the experiments done on mice and micro-spheres. A de-
rived contribution was the demonstration that flow recirculation is not needed in order to
produce platelet aggregation, at least for the micro-flows phenomena.
Despite resources spent and improvements in anti-thrombotic therapies, the majority
of patients receiving these drugs continue to die. The demonstration that the platelet
aggregation process can occur independent of chemical factors, may help explain the
limited anti-thrombotic efficacy of the used drugs, particularly aspirin, clopidogrel and
thrombin inhibitors.
6.1 Outcomes of this work
Through simulations and micro-fabrication it was possible to improve the understand-
ing in the role that mechanical factors play in platelet aggregation. Particular emphasis
was placed on simulations of in-vivo experiments developed in mice (Chapter 3 ), and
micro-sphere disturbance experiments (Chapter 4) where platelet aggregation was found
independently of biochemical activators of aggregation. These simulations set the basis
of the design of a micro-fluidic platform to study the role on the mechanical variables on
108
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platelet aggregation (Chapter 5). The key areas of investigation were: the development
of a model to determine the geometry of a induced stenosis, fluid dynamic simulations to
know the role on blood flow fluid stress of small spherical defects as a flow disturbance
and its impact on platelet aggregation, and finally the design, fabrication, characterisa-
tion and testing of a platform that allows the manipulation of the mechanical variables
in a controlled and independent manner. Each of these goals has been realized with a
summary of the major achievements of this work following.
A primary outcome of this work was the development of a methodology to perform
realistic simulations of the novel experiments of the arteriole geometry deformed by a
micro-needle as presented in Chapter 3. By using this methodology a direct relationship
on how the needle displacement affects the local fluid strain-rate, therefore it was possible
to estimate accurately the order of the strain-rates experienced by the platelets aggregating
at the downstream zone of the stenosis. In the same investigation it was found that the
elastic properties of the arteriole wall affect the local vessel geometry which in turn affect
the strain-rate and mechanical forces experienced by platelets. It was found that the hyper-
elastic nature of the living tissue is determinant in creating local velocity gradients closely
related with platelet aggregates.
Through fluid mechanics theory and simulations conducted in Chapter 4, it was shown
that the flow disturbance produced by a micro-spherical bead is a sudden increase and
decrease in the strain-rate magnitude by a factor of 6. It was demonstrated that the strain-
rate produced by the bead is similar in magnitude across each bead irrespective of bead
diameter. The fact that platelets would experience the same peak strain-rate for each
bead but in fact exhibited different aggregation responses depending on bead diameter,
clearly suggested that it is not only the value of high strain-rates that was promote the
aggregation of platelets but also the deceleration zone that provides a low shear region
where the platelets are allow to recruit.
In Chapter 5 using micro-fabrication technologies in combination with detailed nu-
merical analyses of blood flow, a micro-vascular mimetic platform was fabricated that
closely reproduces the haemodynamics and platelet aggregation dynamics observed in
intra-vital mouse models of acute vascular stenosis. The proof-of-concept data presented
demonstrates that the device has particular utility in enabling the exploration of different
scenarios of controllable fluid strain-rate conditions and should enable a detailed investi-
gation of the role of specific haemodynamics variables regulating platelet aggregation.
Overall the platform technology presented highlights the advantages of microfluidics
and lab on chip devices to study platelet function in response to local changes in strain rate
micro-gradients emulating those found in the vasculature. Once fully characterised this
platform technology should show considerable utility as a clinical and research tool in the
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diagnosis of platelet functional defects in patients experiencing bleeding or thrombotic
diathesis and also in the screening and development of more effective anti-platelet agents
targeting shear-dependent platelet activation mechanisms.
6.2 Suggestions for future work
The work presented in this investigation open the door for interesting projects in micro-
fluidics and blood research. A first area to work on is the computational fluid mechan-
ics. An underlying assumption presented in this thesis was the overall Newtonian and
homogeneous composition of the blood. However better approaches are needed to rep-
resent more closely the haemodynamics experienced by blood flow. In micro-flows the
most distinctive Non-Newtonian features, and particularly in blood, come from the non-
homogeneity, which is given by the deformable blood cells. Therefore, any effort consid-
ering the non-homogeneity of the blood will be worth pursuing further.
A second area quite interesting to investigate further is the experimental validation of
the fluid mechanics. In the current investigation, the experimental validation using µPIV
correlated well with the numerical simulations because in both cases the fluid was con-
sidered homogeneous with constant viscosity and low velocity. However, further studies
and more comprehensive models would be advantageous that take into consideration the
heterogeneity of blood composition (composed of deformable elements), the interaction
between these elements and changes in viscosity as a function of elevated and/or time
varying strain rate. More extensive modeling and experimental investigations need to
be carried out to further define the way in which blood elements such as platelets and
erythrocytes impact on local haemodynamics conditions and mass transport phenomena
to the micro-channel walls. Blood cells can be stained with fluorescence dyes, there-
fore explorations towards the velocimetry of blood flow would be desirable using the
blood platelets themselves as tracer elements. In the same trend, measurements of in-
stantaneous velocimetry during thrombus growth will definitely give further insight in the
haemodynamics regulating thrombosis.
A third area also important is the proper characterisation of the material of the device.
An undefined variable inherent in the micro PDMS micro-channel device presented is
the role of adhesive blood proteins and platelet adhesion receptors in mediating platelet
aggregation in the device. Therefore further studies need to be carried out to identify the
specific plasma protein components and the overall effect of strain rate micro-gradients
on the PDMS protein absorption and its impact on aggregation kinetics.
Another area to further investigate, which is probably the most obvious to the look,
is to study the role of the different variations in the geometry of the stenosis. This is an
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area currently under investigation. Figure 6.1 presents one example of suggested micro-
contractions to study in detail the variables of micro-stenosis using micro-fabrication.
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Figure 6.1: Suggested micro device for future work, in order to study in detail the variables
of micro-stenosis using micro-fabrication. (a) Schematics detailing the main components of the
strain rate micro-gradient device (PDMS chip). [A] 200 µL inlet reservoir for blood delivery.
[B] Trap to prevent micro-channel fouling by particulate matter and/or micro-clots in the blood
sample due to inadequate anticoagulation. [C] Feeder channel connecting the trap zone with the
micro-contraction, [D] six high resolution micro-contractions, [E] exhaust channel and [F] outlet
connection to the syringe pump. (b) Schematic of the micro-contractions allocated in [D].
Overall the platform technology presented highlights the advantages of microfluidics
and lab on chip devices to study platelet function in response to local changes in strain rate
micro-gradients emulating those found in the vasculature. Once fully characterised this
technology platform should show considerable utility as a clinical and research tool in the
diagnosis of platelet functional defects in patients experiencing bleeding or thrombotic
diathesis and also in the screening and development of more effective anti-platelet agents
targeting shear-dependent platelet activation mechanisms.
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